Author,Exposure,Outcome,Direction,Strength,ID,Status,Exposure_Standardized,Outcome_Standardized
,Diabetes,Ischemic stroke,Increase,6.0,1,Final,Diabetes mellitus,Ischemic stroke_1.0
,age,Ischemic stroke,Increase,6.0,1,Final,Age factor,Ischemic stroke_1.0
,age,Diabetes,Increase,5.0,1,Final,Age factor,Diabetes mellitus
,Sex (Male),Ischemic stroke,Increase,6.0,1,Final,Male,Ischemic stroke_1.0
,Hypertension,Ischemic stroke,Increase,6.0,1,Final,Hypertensive disorder,Ischemic stroke_1.0
,age,Hypertension,Increase,6.0,1,Final,Age factor,Hypertensive disorder
,BMI,Hypertension,Increase,4.0,1,Final,Increased body mass index,Hypertensive disorder
,BMI,Diabetes,Increase,4.0,1,Final,Increased body mass index,Diabetes mellitus
,BMI,Ischemic stroke,Increase,6.0,1,Final,Increased body mass index,Ischemic stroke_1.0
Carrero et al (2018),Atrial fibrillation,Ischemic stroke,Increase,6.0,1,Final,Atrial fibrillation,Ischemic stroke_1.0
de Leeuw et al. (2000),Sex (Male),Atrial fibrillation,Increase,4.0,1,Final,Male,Atrial fibrillation
Kalantarian et al. (2014),age,Atrial fibrillation,Increase,5.0,1,Final,Age factor,Atrial fibrillation
,BMI,Atrial fibrillation,Increase,6.0,1,Final,Increased body mass index,Atrial fibrillation
Diez-Villanueva P & Alfonso F. (2019),Hypertension,Atrial fibrillation,Increase,6.0,1,Final,Hypertensive disorder,Atrial fibrillation
,Smoking,Ischemic stroke,Increase,5.0,1,Final,Smoker,Ischemic stroke_1.0
,age,Smoking,Increase,5.0,1,Final,Age factor,Smoker
Pan et al. (2019),Sex (Male),Smoking,Increase,6.0,1,Final,Male,Smoker
Shah & Cole (2010),Smoking,Diabetes,Increase,4.0,1,Final,Smoker,Diabetes mellitus
,Smoking,BMI,Decrease,2.0,1,Final,Smoker,Increased body mass index
,Smoking,Hypertension,Increase,3.0,1,Final,Smoker,Hypertensive disorder
Campagna et al. (2019),Smoking,Atrial fibrillation,Increase,6.0,1,Final,Smoker,Atrial fibrillation
Maddatu et al. (2017),Hyperlipidemia,Atrial fibrillation,Increase,6.0,1,Final,Hyperlipidemia,Atrial fibrillation
Patel et al. (2011),Hyperlipidemia,BMI,Increase,6.0,1,Final,Hyperlipidemia,Increased body mass index
Watanabe et al. (2016),Hyperlipidemia,Hypertension,Increase,6.0,1,Final,Hyperlipidemia,Hypertensive disorder
Halperin et al. (2008),Hyperlipidemia,Diabetes,Increase,6.0,1,Final,Hyperlipidemia,Diabetes mellitus
,Hyperlipidemia,Ischemic stroke,Increase,6.0,1,Final,Hyperlipidemia,Ischemic stroke_1.0
,Diabetes,Atrial fibrillation,Increase,5.0,1,Final,Diabetes mellitus,Atrial fibrillation
,Smoking,Hyperlipidemia,Increase,3.0,1,Final,Smoker,Hyperlipidemia
,Sex (Male),Diabetes,Increase,3.0,1,Final,Male,Diabetes mellitus
,Diabetes,Hypertension,Increase,2.0,1,Final,Diabetes mellitus,Hypertensive disorder
,Hyperlipidemia,GFR,Decrease,2.0,1,Final,Hyperlipidemia,Glomerular filtration rate
Bohne et al. (2019),Sex (Male),BMI,Decrease,2.0,1,Final,Male,Increased body mass index
Sensi et al. (2015),Hypertension,GFR,Decrease,2.0,1,Final,Hypertensive disorder,Glomerular filtration rate
Hallit et al. (2017),Diabetes,GFR,Increase,3.0,1,Final,Diabetes mellitus,Glomerular filtration rate
Jain & Ducatman (2018),Smoking,CKD,Increase,3.0,1,Final,Smoker,Chronic kidney disease
Kautzky-Willer et al. (2016),CKD,Atrial fibrillation,Increase,2.0,1,Final,Chronic kidney disease,Atrial fibrillation
Wishner (1996),CKD,Ischemic stroke,Increase,4.0,1,Final,Chronic kidney disease,Ischemic stroke_1.0
,NIHSS_stroke,NIHSS_followup,Increase,6.0,2,Final,Assessment using National Institutes of Health stroke scale_1.0,Assessment using National Institutes of Health stroke scale_2.0
,NIHSS_stroke,mRS_follow_up,Increase,6.84,2,Final,Assessment using National Institutes of Health stroke scale_1.0,Assessment using Modified Rankin Scale_2.0
,mRS_stroke,mRS_follow_up,Increase,6.84,2,Final,Assessment using Modified Rankin Scale_1.0,Assessment using Modified Rankin Scale_2.0
,mRS_stroke,NIHSS_followup,Increase,6.84,2,Final,Assessment using Modified Rankin Scale_1.0,Assessment using National Institutes of Health stroke scale_2.0
,lesion_size,NIHSS_stroke,Increase,6.84,2,Final,Lesion size,Assessment using National Institutes of Health stroke scale_1.0
,lesion_size,mRS_stroke,Increase,6.84,2,Final,Lesion size,Assessment using Modified Rankin Scale_1.0
,lesion_size,mRS_follow_up,Increase,6.84,2,Final,Lesion size,Assessment using Modified Rankin Scale_2.0
,lesion_size,NIHSS_followup,Increase,6.84,2,Final,Lesion size,Assessment using National Institutes of Health stroke scale_2.0
,time_to_therapy,NIHSS_followup,Increase,6.84,2,Final,Modifier,Assessment using National Institutes of Health stroke scale_2.0
,time_to_therapy,mRS_follow_up,Increase,6.84,2,Final,Modifier,Assessment using Modified Rankin Scale_2.0
,lesion_size,Barthel_Index_stroke,Decrease,6.0,2,Final,Lesion size,Activities of daily living assessment_1.0
eloquent / non-eloquent,lesion_location,Barthel_Index_stroke,Decrease,6.0,2,Final,Finding of lesion,Activities of daily living assessment_1.0
eloquent / non-eloquent,lesion_location,NIHSS_stroke,Increase,6.84,2,Final,Finding of lesion,Assessment using National Institutes of Health stroke scale_1.0
eloquent / non-eloquent,lesion_location,NIHSS_followup,Increase,6.84,2,Final,Finding of lesion,Assessment using National Institutes of Health stroke scale_2.0
eloquent / non-eloquent,lesion_location,mRS_follow_up,Increase,6.84,2,Final,Finding of lesion,Assessment using Modified Rankin Scale_2.0
eloquent / non-eloquent,lesion_location,mRS_stroke,Increase,6.84,2,Final,Finding of lesion,Assessment using Modified Rankin Scale_1.0
,NIHSS_stroke,Barthel_Index_follow_up,Decrease,6.0,2,Final,Assessment using National Institutes of Health stroke scale_1.0,Activities of daily living assessment_2.0
,mRS_stroke,Barthel_Index_follow_up,Decrease,6.0,2,Final,Assessment using Modified Rankin Scale_1.0,Activities of daily living assessment_2.0
,lesion_size,Barthel_Index_follow_up,Decrease,6.0,2,Final,Lesion size,Activities of daily living assessment_2.0
,time_to_therapy,Barthel_Index_follow_up,Decrease,6.0,2,Final,Modifier,Activities of daily living assessment_2.0
,Barthel_Index_stroke,Barthel_Index_follow_up,Increase,6.84,2,Final,Activities of daily living assessment_1.0,Activities of daily living assessment_2.0
eloquent/non eloquent,lesion_location,Barthel_Index_follow_up,Decrease,6.0,2,Final,Finding of lesion,Activities of daily living assessment_2.0
,TOAST (etiology),lesion_size,Increase,6.0,2,Final,Ischemic stroke,Lesion size
,TOAST (etiology),lesion_location,Increase,6.0,2,Final,Ischemic stroke,Finding of lesion
cardioembolic,present atrial fibrillation,TOAST (etiology),Increase,2.68,2,Final,Atrial fibrillation,Ischemic stroke
,time_till_diagnosis,time_to_therapy,Increase,2.68,2,Final,Drug type,Modifier
meaning the general population being aware of typical stroke symptoms,awareness of FAST-Scheme,time_till_diagnosis,Decrease,2.0,2,Final,Unit,Drug type
,time_till_diagnosis,rate of thrombolysis,Decrease,6.84,2,Final,Drug type,Thrombolysis of artery
,time_till_diagnosis,rate of thrombectomy,Decrease,6.84,2,Final,Drug type,Removal of thrombus
,rate of thrombolysis,lesion_size,Decrease,2.93,2,Final,Thrombolysis of artery,Lesion size
,rate of thrombectomy,lesion_size,Decrease,2.93,2,Final,Removal of thrombus,Lesion size
cardioembolic,TOAST (etiology),rate of thrombolysis,Increase,2.93,2,Final,Ischemic stroke,Thrombolysis of artery
accesible arteries,TOAST (etiology),rate of thrombectomy,Increase,2.68,2,Final,Ischemic stroke,Removal of thrombus
macroangiopathic,arteriosklerosis,TOAST (etiology),Increase,2.68,2,Final,Arteriosclerosis,Ischemic stroke
,smoking,arteriosklerosis,Increase,6.84,2,Final,Smoker,Arteriosclerosis
,Age,arteriosklerosis,Increase,6.84,2,Final,Age factor,Arteriosclerosis
,Diabetes mellitus,arteriosklerosis,Increase,6.84,2,Final,Diabetes mellitus,Arteriosclerosis
,Dyslipidemia,arteriosklerosis,Increase,6.84,2,Final,Dyslipidemia,Arteriosclerosis
,Lipoprotein (a),arteriosklerosis,Increase,6.84,2,Final,Lipoprotein (a) hyperlipoproteinemia,Arteriosclerosis
,Vasculitis,arteriosklerosis,Increase,6.84,2,Final,Vasculitis,Arteriosclerosis
cardioembolic,persistent foramen ovale,TOAST (etiology),Increase,6.84,2,Final,Patent foramen ovale,Ischemic stroke
,hypertension,first ischemic stroke,Increase,6.0,3,Draft,Hypertensive disorder,Ischemic stroke_1.0
,BMI_t0,first ischemic stroke,Increase,6.84,3,Draft,Increased body mass index_1.0,Ischemic stroke_1.0
,age,first ischemic stroke,Increase,6.84,3,Draft,Age factor,Ischemic stroke_1.0
,sex(being male),first ischemic stroke,Increase,6.84,3,Draft,Male,Ischemic stroke_1.0
,smoking,first ischemic stroke,Increase,6.84,3,Draft,Smoker,Ischemic stroke_1.0
,diabetes,first ischemic stroke,Increase,6.84,3,Draft,Diabetes mellitus,Ischemic stroke_1.0
,high blood cholesterol levels,first ischemic stroke,Increase,6.84,3,Draft,Hypercholesterolemia,Ischemic stroke_1.0
,high drinking levels,first ischemic stroke,Increase,6.84,3,Draft,Heavy drinker,Ischemic stroke_1.0
,high fat salt diet,first ischemic stroke,Increase,6.0,3,Draft,High fat diet,Ischemic stroke_1.0
,high fat salt diet,hypertension,Increase,2.68,3,Draft,High fat diet,Hypertensive disorder
,atrial fibrillation,first ischemic stroke,Increase,6.0,3,Draft,Atrial fibrillation,Ischemic stroke_1.0
,Atherosclerosis,first ischemic stroke,Increase,6.84,3,Draft,Atherosclerosis,Ischemic stroke_1.0
,high fat salt diet,Atherosclerosis,Increase,0.57,3,Draft,High fat diet,Atherosclerosis
,BMI_t1,second ischemic stroke,Increase,0.57,3,Draft,Increased body mass index_2.0,Ischemic stroke_2.0
,first ischemic stroke,BMI_t1,Decrease,0.57,3,Draft,Ischemic stroke_1.0,Increased body mass index_2.0
,smoking,second ischemic stroke,Increase,6.84,3,Draft,Smoker,Ischemic stroke_2.0
,age,second ischemic stroke,Increase,6.84,3,Draft,Age factor,Ischemic stroke_2.0
,sex(being male),second ischemic stroke,Increase,6.84,3,Draft,Male,Ischemic stroke_2.0
,high drinking levels,second ischemic stroke,Increase,6.84,3,Draft,Heavy drinker,Ischemic stroke_2.0
,high fat salt diet,second ischemic stroke,Increase,6.84,3,Draft,High fat diet,Ischemic stroke_2.0
,diabetes,second ischemic stroke,Increase,6.84,3,Draft,Diabetes mellitus,Ischemic stroke_2.0
,arterial hypertension,endothelial dysfunction,Increase,6.84,4,Draft,Hypertensive disorder,Cardiac syndrome X
,Thrombolysis,functional post stroke outcome,Increase,2.68,4,Draft,Thrombolysis of artery,Assessment using Modified Rankin Scale
,lesion size,functional post stroke outcome,Decrease,6.26,4,Draft,Lesion size,Assessment using Modified Rankin Scale
,arterial hypertension,functional post stroke outcome,Decrease,6.84,4,Draft,Hypertensive disorder,Assessment using Modified Rankin Scale
,Obesity,functional post stroke outcome,Decrease,6.84,4,Draft,Obesity,Assessment using Modified Rankin Scale
,Obesity,endothelial dysfunction,Increase,4.61,4,Draft,Obesity,Cardiac syndrome X
,endothelial dysfunction,EMV,Increase,6.84,4,Draft,Cardiac syndrome X,Drug
,Obesity,1. stroke incidence,Increase,6.84,4,Draft,Obesity,Ischemic stroke_1.0
,arterial hypertension,1. stroke incidence,Increase,6.84,4,Draft,Hypertensive disorder,Ischemic stroke_1.0
,1. stroke incidence,functional post stroke outcome,Decrease,1.0,4,Draft,Ischemic stroke_1.0,Assessment using Modified Rankin Scale
,endothelial dysfunction,1. stroke incidence,Increase,5.42,4,Draft,Cardiac syndrome X,Ischemic stroke_1.0
,EMV,secondary cardiovascular risk,Increase,6.84,4,Draft,Drug,Risk of cardiovascular disease
,arterial hypertension,secondary cardiovascular risk,Increase,6.84,4,Draft,Hypertensive disorder,Risk of cardiovascular disease
,endothelial dysfunction,secondary cardiovascular risk,Increase,2.0,4,Draft,Cardiac syndrome X,Risk of cardiovascular disease
,EMV,1. stroke incidence,Increase,4.0,4,Draft,Drug,Ischemic stroke_1.0
,1. stroke incidence,lesion size,Increase,6.84,4,Draft,Ischemic stroke_1.0,Lesion size
,1. stroke incidence,secondary cardiovascular risk,Increase,6.84,4,Draft,Ischemic stroke_1.0,Risk of cardiovascular disease
,lesion size,secondary cardiovascular risk,Increase,3.0,4,Draft,Lesion size,Risk of cardiovascular disease
,vascular inflammation,secondary cardiovascular risk,Increase,6.84,4,Draft,Vasculitis,Risk of cardiovascular disease
,endothelial dysfunction,vascular inflammation,Increase,3.14,4,Draft,Cardiac syndrome X,Vasculitis
,vascular inflammation,LMV,Increase,5.31,4,Draft,Vasculitis,Race
,LMV,secondary cardiovascular risk,Increase,5.31,4,Draft,Race,Risk of cardiovascular disease
,Smoking,Stroke,Increase,6.0,5,Draft,Smoker,Ischemic stroke_1.0
,kidney disease,Stroke,Increase,5.0,5,Draft,Kidney disease,Ischemic stroke_1.0
,male sex,Stroke,Increase,1.0,5,Draft,Male,Ischemic stroke_1.0
,exercise,Stroke,Decrease,4.0,5,Draft,Exercises regularly,Ischemic stroke_1.0
,male sex,Smoking,Increase,1.0,5,Draft,Male,Smoker
,BMI,Stroke,Increase,5.0,5,Draft,Increased body mass index,Ischemic stroke_1.0
,exercise,BMI,Decrease,6.0,5,Draft,Exercises regularly,Increased body mass index
,dyslipidemia,Stroke,Increase,5.2,5,Draft,Dyslipidemia,Ischemic stroke_1.0
,exercise,kidney disease,Decrease,2.0,5,Draft,Exercises regularly,Kidney disease
,low socioeconomic status,Stroke,Decrease,1.75,5,Draft,Economic status,Ischemic stroke_1.0
,Stroke,Depression,Increase,3.84,5,Draft,Ischemic stroke_1.0,Depressive disorder
,Stroke,Cognitive dysfunction,Increase,3.84,5,Draft,Ischemic stroke_1.0,Impaired cognition
,Stroke,Mortality,Increase,6.84,5,Draft,Ischemic stroke_1.0,Death
Broersen et al. 2020,hs cardiac Troponin,Stroke,Increase,0.94,5,Draft,Cardiac troponin T,Ischemic stroke_1.0
,cardiac disease,hs cardiac Troponin,Increase,5.1,5,Draft,Heart disease,Cardiac troponin T
,cardiac disease,Stroke,Increase,6.84,5,Draft,Heart disease,Ischemic stroke_1.0
,exercise,cardiac disease,Decrease,6.84,5,Draft,Exercises regularly,Heart disease
,Smoking,cardiac disease,Increase,6.26,5,Draft,Smoker,Heart disease
,elevated CRP,Stroke,Increase,3.92,5,Draft,C-reactive protein above reference range,Ischemic stroke_1.0
,low socioeconomic status,Depression,Decrease,3.92,5,Draft,Economic status,Depressive disorder
,age,Stroke,Increase,6.84,5,Draft,Age factor,Ischemic stroke_1.0
,age,cardiac disease,Increase,6.84,5,Draft,Age factor,Heart disease
,high fat/ high carbonhydrate diet,arterial hypertension,Increase,5.0,5,Draft,High fat diet,Hypertensive disorder
,high fat/ high carbonhydrate diet,arterial hypertension,Increase,5.0,5,Draft,High carbohydrate diet,Hypertensive disorder
,high fat/ high carbonhydrate diet,cardiac disease,Increase,5.0,5,Draft,High fat diet,Heart disease
,high fat/ high carbonhydrate diet,cardiac disease,Increase,5.0,5,Draft,High carbohydrate diet,Heart disease
,dyslipidemia,Depression,Increase,3.29,5,Draft,Dyslipidemia,Depressive disorder
,dyslipidemia,Cognitive dysfunction,Increase,3.29,5,Draft,Dyslipidemia,Impaired cognition
,vascular disease,Stroke,Increase,6.84,5,Draft,Vascular disorder,Ischemic stroke_1.0
,age,vascular disease,Increase,3.44,5,Draft,Age factor,Vascular disorder
,vascular disease,kidney disease,Increase,6.84,5,Draft,Vascular disorder,Kidney disease
,diabetes,kidney disease,Increase,6.84,5,Draft,Diabetes mellitus,Kidney disease
,diabetes,Stroke,Increase,6.84,5,Draft,Diabetes mellitus,Ischemic stroke_1.0
,high fat/ high carbonhydrate diet,dyslipidemia,Increase,6.84,5,Draft,High fat diet,Dyslipidemia
,high fat/ high carbonhydrate diet,dyslipidemia,Increase,6.84,5,Draft,High carbohydrate diet,Dyslipidemia
,high fat/ high carbonhydrate diet,diabetes,Increase,6.84,5,Draft,High fat diet,Diabetes mellitus
,high fat/ high carbonhydrate diet,diabetes,Increase,6.84,5,Draft,High carbohydrate diet,Diabetes mellitus
,high fat/ high carbonhydrate diet,elevated CRP,Increase,3.68,5,Draft,High fat diet,C-reactive protein above reference range
,high fat/ high carbonhydrate diet,elevated CRP,Increase,3.68,5,Draft,High carbohydrate diet,C-reactive protein above reference range
,Depression,Mortality,Increase,6.0,5,Draft,Depressive disorder,Death
,coping mechnisms,Depression,Decrease,6.84,5,Draft,Able to cope,Depressive disorder
,low socioeconomic status,high fat/ high carbonhydrate diet,Decrease,2.93,5,Draft,Economic status,High fat diet
,low socioeconomic status,high fat/ high carbonhydrate diet,Decrease,2.93,5,Draft,Economic status,High carbohydrate diet
,habitual alcohol consumption,Stroke,Increase,6.84,5,Draft,Current drinker,Ischemic stroke_1.0
,habitual alcohol consumption,diabetes,Increase,6.84,5,Draft,Current drinker,Diabetes mellitus
,habitual alcohol consumption,coping mechnisms,Decrease,6.13,5,Draft,Current drinker,Able to cope
,exercise,coping mechnisms,Increase,0.51,5,Draft,Exercises regularly,Able to cope
,exercise,arterial hypertension,Decrease,2.72,5,Draft,Exercises regularly,Hypertensive disorder
,exercise,Stroke,Decrease,6.84,5,Draft,Exercises regularly,Ischemic stroke_1.0
,exercise,Mortality,Decrease,6.84,5,Draft,Exercises regularly,Death
,Inflammation,Mortality,Increase,5.0,5,Draft,Inflammation of specific body structures or tissue,Death
,Inflammation,elevated CRP,Increase,6.84,5,Draft,Inflammation of specific body structures or tissue,C-reactive protein above reference range
,Inflammation,Cognitive dysfunction,Increase,1.63,5,Draft,Inflammation of specific body structures or tissue,Impaired cognition
,Inflammation,Depression,Increase,0.51,5,Draft,Inflammation of specific body structures or tissue,Depressive disorder
,habitual alcohol consumption,Inflammation,Increase,3.44,5,Draft,Current drinker,Inflammation of specific body structures or tissue
,low socioeconomic status,habitual alcohol consumption,Decrease,3.44,5,Draft,Economic status,Current drinker
,arterial hypertension,cardiac disease,Increase,6.84,5,Draft,Hypertensive disorder,Heart disease
,Cognitive dysfunction,coping mechnisms,Decrease,2.45,5,Draft,Impaired cognition,Able to cope
,Inflammation,vascular disease,Increase,4.17,5,Draft,Inflammation of specific body structures or tissue,Vascular disorder
,high fat/ high carbonhydrate diet,Inflammation,Increase,4.17,5,Draft,High fat diet,Inflammation of specific body structures or tissue
,high fat/ high carbonhydrate diet,Inflammation,Increase,4.17,5,Draft,High carbohydrate diet,Inflammation of specific body structures or tissue
,Inflammation,cardiac disease,Increase,4.17,5,Draft,Inflammation of specific body structures or tissue,Heart disease
,arterial hypertension,Stroke,Increase,6.84,5,Draft,Hypertensive disorder,Ischemic stroke_1.0
McCarthy 2018,acute heart failure,myocardial infarction (type 2),Increase,6.0,6,Final,Acute heart failure,Myocardial infarction due to demand ischemia
,acute heart failure,mortality,Increase,6.84,6,Final,Acute heart failure,Death
,acute heart failure,nt-pro-BNP,Increase,6.0,6,Final,Acute heart failure,N-terminal pro-B-type natriuretic peptide
,age,diabetes,Increase,4.52,6,Final,Age factor,Diabetes mellitus
,age,FIRST ISCHEMIC STROKE,Increase,6.84,6,Final,Age factor,Ischemic stroke_1.0
,age,atrial fibrillation,Increase,4.34,6,Final,Age factor,Atrial fibrillation
"Bishop, Lu, & Yankner, 2010",age,kognitive decline,Increase,4.0,6,Final,Age factor,Impaired cognition
,age,atherosclerosis,Increase,6.84,6,Final,Age factor,Atherosclerosis
Diener 2020,anticoagulation,second ischemic stroke,Decrease,3.0,6,Final,Anticoagulant therapy,Ischemic stroke_2.0
Diener 2020,anticoagulation,FIRST ISCHEMIC STROKE,Decrease,3.0,6,Final,Anticoagulant therapy,Ischemic stroke_1.0
,anticoagulation,cardiac thrombus,Decrease,2.72,6,Final,Anticoagulant therapy,Thrombus of cardiac chamber
,atherosclerosis,FIRST ISCHEMIC STROKE,Increase,6.68,6,Final,Atherosclerosis,Ischemic stroke_1.0
,atherosclerosis,myocardial infarction (type 1),Increase,6.84,6,Final,Atherosclerosis,Myocardial infarction due to atherothrombotic coronary artery disease
,atrial fibrillation,FIRST ISCHEMIC STROKE,Increase,6.84,6,Final,Atrial fibrillation,Ischemic stroke_1.0
,atrial fibrillation,troponin elevation,Increase,6.0,6,Final,Atrial fibrillation,Troponin
,atrial fibrillation,nt-pro-BNP,Increase,6.0,6,Final,Atrial fibrillation,N-terminal pro-B-type natriuretic peptide
,atrial fibrillation,severe arrrhythmia,Increase,6.0,6,Final,Atrial fibrillation,Cardiac arrhythmia
,BMI,myocardial infarction (type 1),Increase,6.84,6,Final,Increased body mass index,Myocardial infarction due to atherothrombotic coronary artery disease
,BMI,second ischemic stroke,Increase,6.84,6,Final,Increased body mass index,Ischemic stroke_2.0
,BMI,FIRST ISCHEMIC STROKE,Increase,4.34,6,Final,Increased body mass index,Ischemic stroke_1.0
Rizas et al 2017,cardiac autonomic dysbalance,severe arrrhythmia,Increase,4.0,6,Final,Disorder of autonomic nervous system,Cardiac arrhythmia
,cardiac thrombus,FIRST ISCHEMIC STROKE,Increase,5.1,6,Final,Thrombus of cardiac chamber,Ischemic stroke_1.0
,chronic heart failure,kognitive decline,Increase,4.52,6,Final,Chronic heart failure,Impaired cognition
,chronic heart failure,FIRST ISCHEMIC STROKE,Increase,4.34,6,Final,Chronic heart failure,Ischemic stroke_1.0
,chronic heart failure,nt-pro-BNP,Increase,3.22,6,Final,Chronic heart failure,N-terminal pro-B-type natriuretic peptide
,chronic heart failure,troponin elevation,Increase,6.0,6,Final,Chronic heart failure,Troponin
,depression,higher fitness/mobility post,Increase,2.68,6,Final,Depressive disorder_2.0,Physical fitness state_2.0
,depression,higher fitness/mobility post,Increase,2.68,6,Final,Depressive disorder_2.0,Able to mobilize_2.0
,depression,mortality,Increase,2.68,6,Final,Depressive disorder_2.0,Death
Ghadri 2018,depression,Takotsubo syndrome,Increase,2.0,6,Final,Depressive disorder_2.0,Takotsubo cardiomyopathy
,diabetes,mortality,Increase,4.52,6,Final,Diabetes mellitus,Death
,diabetes,infection,Increase,3.22,6,Final,Diabetes mellitus,Infectious disease
,diabetes,myocardial infarction (type 1),Increase,6.0,6,Final,Diabetes mellitus,Myocardial infarction due to atherothrombotic coronary artery disease
,diabetes,FIRST ISCHEMIC STROKE,Increase,4.52,6,Final,Diabetes mellitus,Ischemic stroke_1.0
,diabetes,BMI,Increase,4.52,6,Final,Diabetes mellitus,Increased body mass index
,diabetes,cardiac autonomic dysbalance,Increase,4.0,6,Final,Diabetes mellitus,Disorder of autonomic nervous system
,dissection,FIRST ISCHEMIC STROKE,Increase,3.92,6,Final,Dissection of artery,Ischemic stroke_1.0
,dysphagia,infection,Increase,3.22,6,Final,Dysphagia,Infectious disease
,elevated catecholamines,severe arrrhythmia,Increase,3.76,6,Final,Catecholamine level - finding,Cardiac arrhythmia
Ghadri 2018,elevated catecholamines,Takotsubo syndrome,Increase,6.0,6,Final,Catecholamine level - finding,Takotsubo cardiomyopathy
,exercise (cardiac not excessive),hypertension,Decrease,3.92,6,Final,Exercises regularly,Hypertensive disorder
Diener 2020,exercise (cardiac not excessive),FIRST ISCHEMIC STROKE,Decrease,4.0,6,Final,Exercises regularly,Ischemic stroke_1.0
Strohle et al 2015,exercise (cardiac not excessive),kognitive decline,Decrease,3.0,6,Final,Exercises regularly,Impaired cognition
,exercise (cardiac not excessive),atrial fibrillation,Increase,2.52,6,Final,Exercises regularly,Atrial fibrillation
,exercise (cardiac not excessive),myocardial infarction (type 1),Decrease,2.72,6,Final,Exercises regularly,Myocardial infarction due to atherothrombotic coronary artery disease
,exercise (cardiac not excessive),chronic heart failure,Decrease,3.92,6,Final,Exercises regularly,Chronic heart failure
Scheitz et al 2014,FIRST ISCHEMIC STROKE,troponin elevation,Increase,6.0,6,Final,Ischemic stroke_1.0,Troponin
,FIRST ISCHEMIC STROKE,second ischemic stroke,Increase,6.84,6,Final,Ischemic stroke_1.0,Ischemic stroke_2.0
Diener 2020,FIRST ISCHEMIC STROKE,mortality,Increase,6.0,6,Final,Ischemic stroke_1.0,Death
scheitz 2018,FIRST ISCHEMIC STROKE,acute heart failure,Increase,3.0,6,Final,Ischemic stroke_1.0,Acute heart failure
,FIRST ISCHEMIC STROKE,higher fitness/mobility post,Increase,4.34,6,Final,Ischemic stroke_1.0,Physical fitness state_2.0
,FIRST ISCHEMIC STROKE,higher fitness/mobility post,Increase,4.34,6,Final,Ischemic stroke_1.0,Able to mobilize_2.0
,FIRST ISCHEMIC STROKE,kognitive decline,Increase,4.52,6,Final,Ischemic stroke_1.0,Impaired cognition
Thygesen 2018,FIRST ISCHEMIC STROKE,myocardial infarction (type 2),Increase,6.0,6,Final,Ischemic stroke_1.0,Myocardial infarction due to demand ischemia
,FIRST ISCHEMIC STROKE,depression,Increase,4.61,6,Final,Ischemic stroke_1.0,Depressive disorder_2.0
"Scheitz, Templin 2021 under review",FIRST ISCHEMIC STROKE,Takotsubo syndrome,Increase,3.0,6,Final,Ischemic stroke_1.0,Takotsubo cardiomyopathy
,FIRST ISCHEMIC STROKE,infection,Increase,3.22,6,Final,Ischemic stroke_1.0,Infectious disease
"Scheitz et al, Sposato 2020",FIRST ISCHEMIC STROKE,elevated catecholamines,Increase,2.0,6,Final,Ischemic stroke_1.0,Catecholamine level - finding
,FIRST ISCHEMIC STROKE,seizures,Increase,4.17,6,Final,Ischemic stroke_1.0,Seizure
,FIRST ISCHEMIC STROKE,dysphagia,Increase,3.22,6,Final,Ischemic stroke_1.0,Dysphagia
scheitz et al 2018,FIRST ISCHEMIC STROKE,severe arrrhythmia,Increase,6.0,6,Final,Ischemic stroke_1.0,Cardiac arrhythmia
,higher fitness/mobility post,second ischemic stroke,Decrease,4.34,6,Final,Physical fitness state_2.0,Ischemic stroke_2.0
,higher fitness/mobility post,second ischemic stroke,Decrease,4.34,6,Final,Able to mobilize_2.0,Ischemic stroke_2.0
,higher fitness/mobility pre,FIRST ISCHEMIC STROKE,Increase,4.34,6,Final,Physical fitness state_1.0,Ischemic stroke_1.0
,higher fitness/mobility pre,FIRST ISCHEMIC STROKE,Increase,4.34,6,Final,Able to mobilize_1.0,Ischemic stroke_1.0
,higher fitness/mobility pre,mortality,Increase,6.0,6,Final,Physical fitness state_1.0,Death
,higher fitness/mobility pre,mortality,Increase,6.0,6,Final,Able to mobilize_1.0,Death
,hyperlipidemia,myocardial infarction (type 1),Increase,6.84,6,Final,Hyperlipidemia,Myocardial infarction due to atherothrombotic coronary artery disease
,hyperlipidemia,FIRST ISCHEMIC STROKE,Increase,3.22,6,Final,Hyperlipidemia,Ischemic stroke_1.0
,hypertension,myocardial infarction (type 1),Increase,6.84,6,Final,Hypertensive disorder,Myocardial infarction due to atherothrombotic coronary artery disease
,hypertension,FIRST ISCHEMIC STROKE,Increase,5.1,6,Final,Hypertensive disorder,Ischemic stroke_1.0
,hypertension,dissection,Increase,3.92,6,Final,Hypertensive disorder,Dissection of artery
,hypertension,chronic heart failure,Increase,5.1,6,Final,Hypertensive disorder,Chronic heart failure
Sandoval 2019,hypertension,myocardial infarction (type 2),Increase,4.0,6,Final,Hypertensive disorder,Myocardial infarction due to demand ischemia
,hypertension,acute heart failure,Increase,5.1,6,Final,Hypertensive disorder,Acute heart failure
,infection,mortality,Increase,3.22,6,Final,Infectious disease,Death
Sandoval 2019,infection,myocardial infarction (type 2),Increase,4.0,6,Final,Infectious disease,Myocardial infarction due to demand ischemia
van der Linden 2017,kidney disease,troponin elevation,Increase,2.0,6,Final,Kidney disease,Troponin
,myocardial infarction (type 1),FIRST ISCHEMIC STROKE,Increase,2.68,6,Final,Myocardial infarction due to atherothrombotic coronary artery disease,Ischemic stroke_1.0
Rizas et al 2017,myocardial infarction (type 1),cardiac autonomic dysbalance,Increase,6.0,6,Final,Myocardial infarction due to atherothrombotic coronary artery disease,Disorder of autonomic nervous system
"thygesen et al 2018, McAloon 2016",myocardial infarction (type 1),mortality,Increase,6.0,6,Final,Myocardial infarction due to atherothrombotic coronary artery disease,Death
thygesen et al 2018,myocardial infarction (type 1),severe arrrhythmia,Increase,6.0,6,Final,Myocardial infarction due to atherothrombotic coronary artery disease,Cardiac arrhythmia
thygesen et al 2018,myocardial infarction (type 1),troponin elevation,Increase,6.0,6,Final,Myocardial infarction due to atherothrombotic coronary artery disease,Troponin
Thygesen 2018,myocardial infarction (type 1),acute heart failure,Increase,6.0,6,Final,Myocardial infarction due to atherothrombotic coronary artery disease,Acute heart failure
Thygesen 2018,myocardial infarction (type 1),cardiac thrombus,Increase,5.0,6,Final,Myocardial infarction due to atherothrombotic coronary artery disease,Thrombus of cardiac chamber
,myocardial infarction (type 1),chronic heart failure,Increase,6.84,6,Final,Myocardial infarction due to atherothrombotic coronary artery disease,Chronic heart failure
DeFilippis 2019,myocardial infarction (type 2),troponin elevation,Increase,6.0,6,Final,Myocardial infarction due to demand ischemia,Troponin
McCarthy et al 2018,myocardial infarction (type 2),mortality,Increase,6.0,6,Final,Myocardial infarction due to demand ischemia,Death
Wiktor 2018,persistent foramen ovale,FIRST ISCHEMIC STROKE,Increase,3.0,6,Final,Patent foramen ovale,Ischemic stroke_1.0
,second ischemic stroke,mortality,Increase,6.0,6,Final,Ischemic stroke_2.0,Death
,seizures,mortality,Increase,6.54,6,Final,Seizure,Death
Faria et al 2020,seizures,troponin elevation,Increase,4.0,6,Final,Seizure,Troponin
,severe arrrhythmia,mortality,Increase,6.68,6,Final,Cardiac arrhythmia,Death
,sex (male),smoking,Increase,3.84,6,Final,Male,Smoker
,sex (male),FIRST ISCHEMIC STROKE,Increase,4.34,6,Final,Male,Ischemic stroke_1.0
,sex (male),Takotsubo syndrome,Decrease,2.68,6,Final,Male,Takotsubo cardiomyopathy
,smoking,FIRST ISCHEMIC STROKE,Increase,6.84,6,Final,Smoker,Ischemic stroke_1.0
,smoking,myocardial infarction (type 1),Increase,6.84,6,Final,Smoker,Myocardial infarction due to atherothrombotic coronary artery disease
,stroke lesion affecting central autonomic network,cardiac autonomic dysbalance,Increase,2.72,6,Final,Lesion of brain,Disorder of autonomic nervous system
Scheitz et.al 2018 lancet,stroke lesion affecting central autonomic network,severe arrrhythmia,Increase,6.0,6,Final,Lesion of brain,Cardiac arrhythmia
Krause et al 2017,stroke lesion affecting central autonomic network,troponin elevation,Increase,6.0,6,Final,Lesion of brain,Troponin
Scheitz 2018,stroke lesion affecting central autonomic network,elevated catecholamines,Increase,2.0,6,Final,Lesion of brain,Catecholamine level - finding
Ghadri et at 2018,Takotsubo syndrome,troponin elevation,Increase,4.0,6,Final,Takotsubo cardiomyopathy,Troponin
scheitz 2014,troponin elevation,higher fitness/mobility post,Increase,3.0,6,Final,Troponin,Physical fitness state_2.0
scheitz 2014,troponin elevation,higher fitness/mobility post,Increase,3.0,6,Final,Troponin,Able to mobilize_2.0
broersen et al 2020,troponin elevation,kognitive decline,Increase,4.0,6,Final,Troponin,Impaired cognition
,age,first-ever ischemic stroke occurence,Increase,6.84,7,Final,Age factor,Ischemic stroke_1.0
,sex (being male),first-ever ischemic stroke occurence,Increase,6.84,7,Final,Male,Ischemic stroke_1.0
,BMI,first-ever ischemic stroke occurence,Increase,6.84,7,Final,Increased body mass index,Ischemic stroke_1.0
Gorelick et al (1997),LDL-cholesterol,first-ever ischemic stroke occurence,Increase,6.0,7,Final,Hypercholesterolemia,Ischemic stroke_1.0
MacMahon et al (1990),blood pressure,first-ever ischemic stroke occurence,Increase,6.0,7,Final,Hypertensive disorder,Ischemic stroke_1.0
,BMI,LDL-cholesterol,Increase,6.84,7,Final,Increased body mass index,Hypercholesterolemia
,BMI,blood pressure,Increase,6.84,7,Final,Increased body mass index,Hypertensive disorder
,LDL-cholesterol,atherosclerosis (measured by low ABI),Increase,6.84,7,Final,Hypercholesterolemia,Atherosclerosis
,atrial fibrilation,first-ever ischemic stroke occurence,Increase,6.84,7,Final,Atrial fibrillation,Ischemic stroke_1.0
,occurence of myocardial infarction,first-ever ischemic stroke occurence,Increase,4.17,7,Final,Myocardial infarction,Ischemic stroke_1.0
Shinton et al (1999),smoking,first-ever ischemic stroke occurence,Increase,6.0,7,Final,Smoker,Ischemic stroke_1.0
Wilhelmsson et al (1975),smoking,occurence of myocardial infarction,Increase,6.0,7,Final,Smoker,Myocardial infarction
,smoking,blood pressure,Increase,6.84,7,Final,Smoker,Hypertensive disorder
,smoking,atherosclerosis (measured by low ABI),Increase,6.84,7,Final,Smoker,Atherosclerosis
,first-ever ischemic stroke occurence,second ischemic stroke occurence,Increase,6.84,7,Final,Ischemic stroke_1.0,Ischemic stroke_2.0
,LDL-cholesterol,second ischemic stroke occurence,Increase,6.84,7,Final,Hypercholesterolemia,Ischemic stroke_2.0
,LDL-cholesterol,second ischemic stroke occurence,Increase,2.58,7,Final,Hypercholesterolemia,Ischemic stroke_2.0
,age,second ischemic stroke occurence,Increase,2.68,7,Final,Age factor,Ischemic stroke_2.0
,BMI,second ischemic stroke occurence,Increase,2.68,7,Final,Increased body mass index,Ischemic stroke_2.0
,atherosclerosis (measured by low ABI),second ischemic stroke occurence,Increase,2.68,7,Final,Atherosclerosis,Ischemic stroke_2.0
,atrial fibrilation,second ischemic stroke occurence,Increase,2.68,7,Final,Atrial fibrillation,Ischemic stroke_2.0
,occurence of myocardial infarction,second ischemic stroke occurence,Increase,2.68,7,Final,Myocardial infarction,Ischemic stroke_2.0
,smoking,second ischemic stroke occurence,Increase,2.68,7,Final,Smoker,Ischemic stroke_2.0
,anticoagulation medication,first-ever ischemic stroke occurence,Decrease,2.68,7,Final,Anticoagulant therapy,Ischemic stroke_1.0
Schneider et al. (2004),first-ever ischemic stroke occurence,cognitive function,Increase,2.0,7,Final,Ischemic stroke_1.0,Impaired cognition
Snowdon et al. (1997),second ischemic stroke occurence,cognitive function,Increase,2.0,7,Final,Ischemic stroke_2.0,Impaired cognition
Schneider et al. (2014),atherosclerosis (measured by low ABI),cognitive function,Increase,2.0,7,Final,Atherosclerosis,Impaired cognition
Guerchet et al (2011),age,cognitive function,Increase,2.68,7,Final,Age factor,Impaired cognition
,diabetes mellitus,first-ever ischemic stroke occurence,Increase,2.0,7,Final,Diabetes mellitus,Ischemic stroke_1.0
Kannell et al (1979),diabetes mellitus,second ischemic stroke occurence,Increase,2.68,7,Final,Diabetes mellitus,Ischemic stroke_2.0
,diabetes mellitus,occurence of myocardial infarction,Increase,2.68,7,Final,Diabetes mellitus,Myocardial infarction
,diabetes mellitus,atherosclerosis (measured by low ABI),Increase,2.68,7,Final,Diabetes mellitus,Atherosclerosis
,sex (being male),atherosclerosis (measured by low ABI),Increase,2.68,7,Final,Male,Atherosclerosis
,BMI,diabetes mellitus,Increase,2.68,7,Final,Increased body mass index,Diabetes mellitus
,age,diabetes mellitus,Increase,2.68,7,Final,Age factor,Diabetes mellitus
,exercise,first-ever ischemic stroke occurence,Decrease,2.68,7,Final,Exercises regularly,Ischemic stroke_1.0
,exercise,BMI,Decrease,2.68,7,Final,Exercises regularly,Increased body mass index
,exercise,LDL-cholesterol,Decrease,0.83,7,Final,Exercises regularly,Hypercholesterolemia
,exercise,blood pressure,Decrease,3.29,7,Final,Exercises regularly,Hypertensive disorder
,exercise,atherosclerosis (measured by low ABI),Decrease,0.78,7,Final,Exercises regularly,Atherosclerosis
,exercise,occurence of myocardial infarction,Decrease,3.29,7,Final,Exercises regularly,Myocardial infarction
,exercise,second ischemic stroke occurence,Decrease,3.29,7,Final,Exercises regularly,Ischemic stroke_2.0
,exercise,diabetes mellitus,Decrease,3.6,7,Final,Exercises regularly,Diabetes mellitus
,infectious endocarditis,first-ever ischemic stroke occurence,Increase,3.6,7,Final,Acute infective endocarditis,Ischemic stroke_1.0
,alcohol consumption,first-ever ischemic stroke occurence,Increase,3.6,7,Final,Current drinker,Ischemic stroke_1.0
,alcohol consumption,second ischemic stroke occurence,Increase,1.46,7,Final,Current drinker,Ischemic stroke_2.0
,alcohol consumption,blood pressure,Increase,1.46,7,Final,Current drinker,Hypertensive disorder
,age,alcohol consumption,Increase,0.89,7,Final,Age factor,Current drinker
,sex (being male),alcohol consumption,Increase,1.81,7,Final,Male,Current drinker
,stress,first-ever ischemic stroke occurence,Increase,2.58,7,Final,Stress,Ischemic stroke_1.0
,stress,blood pressure,Increase,2.58,7,Final,Stress,Hypertensive disorder
,stress,occurence of myocardial infarction,Increase,2.58,7,Final,Stress,Myocardial infarction
,stress,smoking,Increase,1.11,7,Final,Stress,Smoker
,stress,second ischemic stroke occurence,Increase,1.11,7,Final,Stress,Ischemic stroke_2.0
,stress,alcohol consumption,Increase,1.11,7,Final,Stress,Current drinker
,stress,atherosclerosis (measured by low ABI),Increase,1.11,7,Final,Stress,Atherosclerosis
,diabetes mellitus,cognitive function,Increase,2.0,7,Final,Diabetes mellitus,Impaired cognition
Knopman et al (2001),statin use,first-ever ischemic stroke occurence,Decrease,1.0,7,Final,Administration of prophylactic statin,Ischemic stroke_1.0
Hebert et al (1997),statin use,LDL-cholesterol,Decrease,4.8,7,Final,Administration of prophylactic statin,Hypercholesterolemia
,statin use,atherosclerosis (measured by low ABI),Decrease,1.4,7,Final,Administration of prophylactic statin,Atherosclerosis
,statin use,occurence of myocardial infarction,Decrease,2.86,7,Final,Administration of prophylactic statin,Myocardial infarction
,Lipoprotein a,first-ever ischemic stroke occurence,Increase,2.0,7,Final,Lipoprotein (a) hyperlipoproteinemia,Ischemic stroke_1.0
Nave et al (2015),Lipoprotein a,atherosclerosis (measured by low ABI),Increase,2.68,7,Final,Lipoprotein (a) hyperlipoproteinemia,Atherosclerosis
,atherosclerosis (measured by low ABI),first-ever ischemic stroke occurence,Increase,5.0,7,Final,Atherosclerosis,Ischemic stroke_1.0
Hong et al. (2016),blood pressure,cognitive function,Increase,2.68,7,Final,Hypertensive disorder,Impaired cognition
Knopman et al (2001),antihypertensive medicatio,first-ever ischemic stroke occurence,Decrease,2.68,7,Final,Antihypertensive therapy,Ischemic stroke_1.0
Collins et al (1990),antihypertensive medicatio,occurence of myocardial infarction,Decrease,2.68,7,Final,Antihypertensive therapy,Myocardial infarction
Collins et al (1990),BMI,atherosclerosis (measured by low ABI),Increase,2.68,7,Final,Increased body mass index,Atherosclerosis
McGill et al (2002),BMI,occurence of myocardial infarction,Increase,2.68,7,Final,Increased body mass index,Myocardial infarction
Burn et al. (1994),first ischemic stroke,second ischemic stroke,Increase,6.84,9,Final,Ischemic stroke_1.0,Ischemic stroke_2.0
Brønnum-Hansen et al. (2001),first ischemic stroke,mortality,Increase,6.84,9,Final,Ischemic stroke_1.0,Death
Hankey et al. (2002),first ischemic stroke,disability,Increase,6.84,9,Final,Ischemic stroke_1.0,Disability
Davenport et al. (1996),first ischemic stroke,pneumonia,Increase,6.0,9,Final,Ischemic stroke_1.0,Pneumonia
Johnston et al. (1998),first ischemic stroke,urinary tract infection,Increase,6.0,9,Final,Ischemic stroke_1.0,Urinary tract infectious disease
Davenport et al. (1996),pneumonia,mortality,Increase,6.0,9,Final,Pneumonia,Death
Finlayson et al. (2011),second ischemic stroke,mortality,Increase,2.68,9,Final,Ischemic stroke_2.0,Death
Poisson et al. (2010),second ischemic stroke,disability,Increase,2.68,9,Final,Ischemic stroke_2.0,Disability
Ersoz et al. (2007),urinary catheter placement,urinary tract infection,Increase,6.0,9,Final,Procedure involving urinary catheter,Urinary tract infectious disease
van der Worp & Kappelle (1998),first ischemic stroke,bladder dysfunction,Increase,6.0,9,Final,Ischemic stroke_1.0,Dysfunction of urinary bladder
,first ischemic stroke,urinary catheter placement,Increase,2.0,9,Final,Ischemic stroke_1.0,Procedure involving urinary catheter
Poisson et al. (2010),bladder dysfunction,urinary tract infection,Increase,2.68,9,Final,Dysfunction of urinary bladder,Urinary tract infectious disease
,first ischemic stroke,immunosuppression,Increase,0.51,9,Final,Ischemic stroke_1.0,Immunosuppression
Maki & Tambyah (2001),immunosuppression,urinary tract infection,Increase,0.51,9,Final,Immunosuppression,Urinary tract infectious disease
Gould et al. (2010),sex(female),urinary tract infection,Increase,6.0,9,Final,Male,Urinary tract infectious disease
Kong & Young (2000),age,urinary tract infection,Increase,6.0,9,Final,Age factor,Urinary tract infectious disease
Poisson et al. (2010),age,first ischemic stroke,Increase,6.0,9,Final,Age factor,Ischemic stroke_1.0
,urinary tract infection,mortality,Increase,0.51,9,Final,Urinary tract infectious disease,Death
Poisson et al. (2010),urinary tract infection,disability,Increase,0.51,9,Final,Urinary tract infectious disease,Disability
Poisson et al. (2010),first ischemic stroke,body temperature,Increase,0.51,9,Final,Ischemic stroke_1.0,Body temperature above reference range
Azzimondi et al. (1995),urinary tract infection,body temperature,Increase,6.84,9,Final,Urinary tract infectious disease,Body temperature above reference range
Boysen & Christensen (2001),pneumonia,body temperature,Increase,6.84,9,Final,Pneumonia,Body temperature above reference range
,body temperature,mortality,Increase,0.51,9,Final,Body temperature above reference range,Death
,body temperature,disability,Increase,0.51,9,Final,Body temperature above reference range,Disability
Jauch et al. (2013),first ischemic stroke,delirium,Increase,0.51,9,Final,Ischemic stroke_1.0,Delirium
Jauch et al. (2013),age,delirium,Increase,6.84,9,Final,Age factor,Delirium
Oldenbeuving et al. (2007),urinary tract infection,delirium,Increase,0.51,9,Final,Urinary tract infectious disease,Delirium
Oldenbeuving et al. (2007),pneumonia,delirium,Increase,0.51,9,Final,Pneumonia,Delirium
Oldenbeuving et al. (2007),delirium,disability,Increase,0.51,9,Final,Delirium,Disability
Oldenbeuving et al. (2007),stroke unit care,delirium,Decrease,0.51,9,Final,Admission to stroke unit,Delirium
Oldenbeuving et al. (2007),bladder dysfunction,urinary catheter placement,Increase,0.51,9,Final,Dysfunction of urinary bladder,Procedure involving urinary catheter
Oldenbeuving et al. (2007),age,pneumonia,Increase,2.68,9,Final,Age factor,Pneumonia
,pneumonia,disability,Increase,0.51,9,Final,Pneumonia,Disability
Finlayson et al. (2011),first ischemic stroke,dysphagia,Increase,6.0,9,Final,Ischemic stroke_1.0,Dysphagia
Finlayson et al. (2011),dysphagia,pneumonia,Increase,6.84,9,Final,Dysphagia,Pneumonia
Martino et al. (2005),dysphagia,aspiration,Increase,6.84,9,Final,Dysphagia,Aspiration
Martino et al. (2005),aspiration,pneumonia,Increase,6.84,9,Final,Aspiration,Pneumonia
Martino et al. (2005),smoking,first ischemic stroke,Increase,6.84,9,Final,Smoker,Ischemic stroke_1.0
Martino et al. (2005),smoking,second ischemic stroke,Increase,6.84,9,Final,Smoker,Ischemic stroke_2.0
,sex(male),first ischemic stroke,Increase,6.84,9,Final,Male,Ischemic stroke_1.0
,atrial fibrillation,first ischemic stroke,Increase,6.84,9,Final,Atrial fibrillation,Ischemic stroke_1.0
,BMI,first ischemic stroke,Increase,6.84,9,Final,Increased body mass index,Ischemic stroke_1.0
,atrial fibrillation,second ischemic stroke,Increase,6.84,9,Final,Atrial fibrillation,Ischemic stroke_2.0
,BMI,second ischemic stroke,Increase,6.84,9,Final,Increased body mass index,Ischemic stroke_2.0
,blood pressure,first ischemic stroke,Increase,6.84,9,Final,Hypertensive disorder,Ischemic stroke_1.0
,blood pressure,second ischemic stroke,Increase,6.84,9,Final,Hypertensive disorder,Ischemic stroke_2.0
,age,blood pressure,Increase,6.84,9,Final,Age factor,Hypertensive disorder
,age,smoking,Decrease,2.93,9,Final,Age factor,Smoker
,first ischemic stroke,stroke unit care,Increase,6.84,9,Final,Ischemic stroke_1.0,Admission to stroke unit
,blood lipids,first ischemic stroke,Increase,6.84,9,Final,Hyperlipidemia,Ischemic stroke_1.0
Jauch et al. (2013),diabetes,first ischemic stroke,Increase,6.84,9,Final,Diabetes mellitus,Ischemic stroke_1.0
,first ischemic stroke,blood glucose,Increase,6.0,9,Final,Ischemic stroke_1.0,Blood glucose level - finding
Khoury et al. (2013),diabetes,blood glucose,Increase,6.0,9,Final,Diabetes mellitus,Blood glucose level - finding
Jauch et al. (2013),age,diabetes,Increase,2.68,9,Final,Age factor,Diabetes mellitus
,BMI,diabetes,Increase,2.68,9,Final,Increased body mass index,Diabetes mellitus
,sex(male),smoking,Increase,2.68,9,Final,Male,Smoker
Langhorne et al. (2020),stroke unit care,mortality,Decrease,4.71,9,Final,Admission to stroke unit,Death
Langhorne et al. (2020),stroke unit care,disability,Decrease,4.17,9,Final,Admission to stroke unit,Disability
Touzé et al. (2005),first ischemic stroke,myocardial infarction,Increase,1.0,9,Final,Ischemic stroke_1.0,Myocardial infarction
,myocardial infarction,mortality,Increase,6.0,9,Final,Myocardial infarction,Death
Sulter et al. (2000),first ischemic stroke,oxygen saturation,Decrease,5.0,9,Final,Ischemic stroke_1.0,Finding of oxygen saturation
Rowat et al. (2006),patient positioning,oxygen saturation,Increase,0.51,9,Final,Patient position finding,Finding of oxygen saturation
Rowat et al. (2001),pneumonia,oxygen saturation,Decrease,6.84,9,Final,Pneumonia,Finding of oxygen saturation
,age,oxygen saturation,Decrease,0.51,9,Final,Age factor,Finding of oxygen saturation
Sulter et al. (2000),dysphagia,oxygen saturation,Decrease,0.51,9,Final,Dysphagia,Finding of oxygen saturation
Sulter et al. (2000),oxygen saturation,mortality,Decrease,0.51,9,Final,Finding of oxygen saturation,Death
Rowat et al. (2006),first ischemic stroke,dependency,Increase,6.0,9,Final,Ischemic stroke_1.0,Functionally dependent
,disability,dependency,Increase,6.0,9,Final,Disability,Functionally dependent
,dysphagia,dependency,Increase,2.68,9,Final,Dysphagia,Functionally dependent
Martino et al. (2005),first ischemic stroke,urinary incontinence,Increase,2.68,9,Final,Ischemic stroke_1.0,Urinary incontinence
Nakayama et al. (1997),age,urinary incontinence,Increase,2.68,9,Final,Age factor,Urinary incontinence
Nakayama et al. (1997),urinary incontinence,dependency,Increase,2.68,9,Final,Urinary incontinence,Functionally dependent
Patel et al. (2001),diabetes,urinary incontinence,Increase,0.51,9,Final,Diabetes mellitus,Urinary incontinence
,urinary incontinence,urinary catheter placement,Increase,0.51,9,Final,Urinary incontinence,Procedure involving urinary catheter
,first ischemic stroke,paralysis,Increase,6.84,9,Final,Ischemic stroke_1.0,Paralysis
,paralysis,disability,Increase,6.84,9,Final,Paralysis,Disability
,paralysis,dependency,Increase,6.84,9,Final,Paralysis,Functionally dependent
,first ischemic stroke,deep vein thrombosis,Increase,6.84,9,Final,Ischemic stroke_1.0,Deep venous thrombosis
Kappelle et al. (2011),paralysis,deep vein thrombosis,Increase,6.84,9,Final,Paralysis,Deep venous thrombosis
Kappelle et al. (2011),deep vein thrombosis,pulmonary embolism,Increase,6.84,9,Final,Deep venous thrombosis,Pulmonary embolism
,pulmonary embolism,mortality,Increase,6.84,9,Final,Pulmonary embolism,Death
,pulmonary embolism,oxygen saturation,Decrease,6.84,9,Final,Pulmonary embolism,Finding of oxygen saturation
,paralysis,pneumonia,Increase,2.0,9,Final,Paralysis,Pneumonia
,first ischemic stroke,falls,Increase,6.0,9,Final,Ischemic stroke_1.0,Falls
Wei et al. (2019),age,falls,Increase,2.68,9,Final,Age factor,Falls
,urinary incontinence,falls,Increase,2.68,9,Final,Urinary incontinence,Falls
,delirium,falls,Increase,2.68,9,Final,Delirium,Falls
,falls,fractures,Increase,2.0,9,Final,Falls,Fracture of bone
Melton et al. (2001),first ischemic stroke,fractures,Increase,2.68,9,Final,Ischemic stroke_1.0,Fracture of bone
Kanis et al. (2001),fractures,disability,Increase,0.51,9,Final,Fracture of bone,Disability
,fractures,dependency,Increase,0.51,9,Final,Fracture of bone,Functionally dependent
,physical activity,first ischemic stroke,Increase,6.84,9,Final,Exercises regularly,Ischemic stroke_1.0
low or very high,alcohol consumption,first ischemic stroke,Increase,3.84,9,Final,Current drinker,Ischemic stroke_1.0
,atherosclerosis,first ischemic stroke,Increase,6.0,9,Final,Atherosclerosis,Ischemic stroke_1.0
,blood lipids,second ischemic stroke,Increase,6.0,9,Final,Hyperlipidemia,Ischemic stroke_2.0
,alcohol consumption,second ischemic stroke,Increase,3.0,9,Final,Current drinker,Ischemic stroke_2.0
,physical activity,second ischemic stroke,Increase,6.0,9,Final,Exercises regularly,Ischemic stroke_2.0
,education,first ischemic stroke,Decrease,1.0,9,Final,Education and/or schooling finding,Ischemic stroke_1.0
Reshetnyak et al. (2020),income,first ischemic stroke,Decrease,1.0,9,Final,Economic status,Ischemic stroke_1.0
Reshetnyak et al. (2020),social isolation,first ischemic stroke,Increase,0.51,9,Final,Social isolation,Ischemic stroke_1.0
Reshetnyak et al. (2020),TIA,first ischemic stroke,Increase,6.84,9,Final,Transient cerebral ischemia,Ischemic stroke_1.0
O'Donnell et al. 2016,Smoking,first ischemic stroke,Increase,6.84,10,Final,Smoker,Ischemic stroke_1.0
O'Donnell et al. 2016,Diabetes mellitus,first ischemic stroke,Increase,6.84,10,Final,Diabetes mellitus,Ischemic stroke_1.0
O'Donnell et al. 2016,moderate physical activity,first ischemic stroke,Decrease,6.84,10,Final,Exercises regularly,Ischemic stroke_1.0
,moderate physical activity,Diabetes mellitus,Decrease,6.84,10,Final,Exercises regularly,Diabetes mellitus
"O'Donnell et al. 2016, Paterson et al. 2018",healthy (mediterranean) diet,first ischemic stroke,Decrease,6.84,10,Final,Mediterranean diet,Ischemic stroke_1.0
,healthy (mediterranean) diet,Diabetes mellitus,Decrease,3.92,10,Final,Mediterranean diet,Diabetes mellitus
"Ebrahim et al., 2006",hyperlipoproteinemia (high LDL),first ischemic stroke,Increase,6.0,10,Final,Hypercholesterolemia,Ischemic stroke_1.0
,atrial fibrillation,first ischemic stroke,Increase,6.84,10,Final,Atrial fibrillation,Ischemic stroke_1.0
,dissection of cerebral vessel,first ischemic stroke,Increase,6.84,10,Final,Dissection of cerebral artery,Ischemic stroke_1.0
,atherosclerosis,first ischemic stroke,Increase,6.84,10,Final,Atherosclerosis,Ischemic stroke_1.0
,hyperlipoproteinemia (high LDL),atherosclerosis,Increase,6.84,10,Final,Hypercholesterolemia,Atherosclerosis
,positive familiy history of cardio/cerebrovascular events,first ischemic stroke,Increase,6.84,10,Final,Family history of stroke,Ischemic stroke_1.0
,positive familiy history of cardio/cerebrovascular events,first ischemic stroke,Increase,6.84,10,Final,FH: Cardiovascular disease,Ischemic stroke_1.0
,stenoses of cerebral vessels,first ischemic stroke,Increase,4.17,10,Final,Stenosis,Ischemic stroke_1.0
,atherosclerosis,stenoses of cerebral vessels,Increase,6.84,10,Final,Atherosclerosis,Stenosis
,dissection of cerebral vessel,stenoses of cerebral vessels,Increase,6.84,10,Final,Dissection of cerebral artery,Stenosis
In patients where no other risk factors are found and the PFO shows a right-->left shunt and shows a hypermobile septum,patent foramen ovale (PFO),first ischemic stroke,Increase,3.52,10,Final,Patent foramen ovale,Ischemic stroke_1.0
Bushnell at el. 2014,oral contraceptives,first ischemic stroke,Increase,3.0,10,Final,Uses oral contraception,Ischemic stroke_1.0
in women with other cardiovascular risk factors or vessels that are sensitive to homonal changes,depression,first ischemic stroke,Increase,3.0,10,Final,Depressive disorder_2.0,Ischemic stroke_1.0
"O'Donnell et al., 2010",antidepressive medication,first ischemic stroke,Increase,3.52,10,Final,Antidepressant therapy,Ischemic stroke_1.0
,depression,antidepressive medication,Increase,3.52,10,Final,Depressive disorder_2.0,Antidepressant therapy
,antiplatelet therapy (e.g. ASS),first ischemic stroke,Decrease,6.0,10,Final,Platelet aggregation inhibitor therapy,Ischemic stroke_1.0
In patients with high cardiovascular risk profile,Statins,first ischemic stroke,Decrease,6.84,10,Final,Administration of prophylactic statin,Ischemic stroke_1.0
"In patients with high cardiovascular risk profile, especially high LDL-Cholesterine",Statins,hyperlipoproteinemia (high LDL),Decrease,6.0,10,Final,Administration of prophylactic statin,Hypercholesterolemia
"Law et al., 2003",first ischemic stroke,second ischemic stroke,Increase,6.0,10,Final,Ischemic stroke_1.0,Ischemic stroke_2.0
"Khanevski et al., 2019",age,hyperlipoproteinemia (high LDL),Increase,4.34,10,Final,Age factor,Hypercholesterolemia
,age,atrial fibrillation,Increase,6.84,10,Final,Age factor,Atrial fibrillation
,age,patent foramen ovale (PFO),Decrease,3.68,10,Final,Age factor,Patent foramen ovale
,age,first ischemic stroke,Increase,6.84,10,Final,Age factor,Ischemic stroke_1.0
,arterial hypertension,first ischemic stroke,Increase,6.84,10,Final,Hypertensive disorder,Ischemic stroke_1.0
O'Donnell et al 2016,age,death (all causes),Increase,6.0,10,Final,Age factor,Death
,age,arterial hypertension,Increase,6.84,10,Final,Age factor,Hypertensive disorder
,age,second ischemic stroke,Increase,6.0,10,Final,Age factor,Ischemic stroke_2.0
"Khanevski et al., 2019",Smoking,second ischemic stroke,Increase,6.84,10,Final,Smoker,Ischemic stroke_2.0
,Diabetes mellitus,second ischemic stroke,Increase,6.84,10,Final,Diabetes mellitus,Ischemic stroke_2.0
,hyperlipoproteinemia (high LDL),second ischemic stroke,Increase,6.84,10,Final,Hypercholesterolemia,Ischemic stroke_2.0
,moderate physical activity,second ischemic stroke,Decrease,6.84,10,Final,Exercises regularly,Ischemic stroke_2.0
,healthy (mediterranean) diet,second ischemic stroke,Decrease,6.84,10,Final,Mediterranean diet,Ischemic stroke_2.0
,atrial fibrillation,second ischemic stroke,Increase,6.84,10,Final,Atrial fibrillation,Ischemic stroke_2.0
,dissection of cerebral vessel,second ischemic stroke,Increase,6.84,10,Final,Dissection of cerebral artery,Ischemic stroke_2.0
,atherosclerosis,second ischemic stroke,Increase,6.84,10,Final,Atherosclerosis,Ischemic stroke_2.0
,positive familiy history of cardio/cerebrovascular events,second ischemic stroke,Increase,3.6,10,Final,Family history of stroke,Ischemic stroke_2.0
,positive familiy history of cardio/cerebrovascular events,second ischemic stroke,Increase,3.6,10,Final,FH: Cardiovascular disease,Ischemic stroke_2.0
,stenoses of cerebral vessels,second ischemic stroke,Increase,3.6,10,Final,Stenosis,Ischemic stroke_2.0
,antiplatelet therapy (e.g. ASS),second ischemic stroke,Decrease,6.0,10,Final,Platelet aggregation inhibitor therapy,Ischemic stroke_2.0
Kernan et al. 2014,Statins,second ischemic stroke,Decrease,6.0,10,Final,Administration of prophylactic statin,Ischemic stroke_2.0
"Amarenco et al., 2020",first ischemic stroke,post stroke epilepsy,Increase,5.31,10,Final,Ischemic stroke_1.0,Epilepsy due to cerebrovascular accident
Browne and Holmes 2001,second ischemic stroke,post stroke epilepsy,Increase,6.84,10,Final,Ischemic stroke_2.0,Epilepsy due to cerebrovascular accident
Browne and Holmes 2001,stroke severity (e.g. measured by NIHSS),post stroke epilepsy,Increase,6.0,10,Final,Assessment using National Institutes of Health stroke scale,Epilepsy due to cerebrovascular accident
"Slapo et al., 2006",post stroke epilepsy,functional outcome (e.g. measured by mRS),Increase,4.0,10,Final,Epilepsy due to cerebrovascular accident,Assessment using Modified Rankin Scale
Arntz et al. 2013,stroke severity (e.g. measured by NIHSS),functional outcome (e.g. measured by mRS),Increase,4.26,10,Final,Assessment using National Institutes of Health stroke scale,Assessment using Modified Rankin Scale
Arntz et al. 2013,obesity,first ischemic stroke,Increase,5.76,10,Final,Obesity,Ischemic stroke_1.0
,obesity,second ischemic stroke,Increase,5.76,10,Final,Obesity,Ischemic stroke_2.0
"Kernan et al., 2014 (AHA/ASA Guideline)",sleep apnea,first ischemic stroke,Increase,5.76,10,Final,Sleep apnea,Ischemic stroke_1.0
"Kernan et al., 2014 (AHA/ASA Guideline)",sleep apnea,second ischemic stroke,Increase,5.76,10,Final,Sleep apnea,Ischemic stroke_2.0
"Kernan et al., 2014 (AHA/ASA Guideline)",obesity,sleep apnea,Increase,3.29,10,Final,Obesity,Sleep apnea
"Kernan et al., 2014 (AHA/ASA Guideline)",anticoagulation,first ischemic stroke,Decrease,6.84,10,Final,Anticoagulant therapy,Ischemic stroke_1.0
,anticoagulation,second ischemic stroke,Decrease,6.84,10,Final,Anticoagulant therapy,Ischemic stroke_2.0
Kernan et al. 2014 (for some patients patients with atrial fibrillation and some patients with thrombophilia),low socioeconomic status,death (all causes),Decrease,4.43,10,Final,Economic status,Death
Kernan et al. 2014 (for patients patients with atrial fibrillation and some patients with thrombophilia),post stroke epilepsy,death (all causes),Increase,6.26,10,Final,Epilepsy due to cerebrovascular accident,Death
"Vivanco-Hidalgo et al., 2019",arterial hypertension,second ischemic stroke,Increase,6.0,10,Final,Hypertensive disorder,Ischemic stroke_2.0
Arrich et al. 2005,arterial hypertension,atherosclerosis,Increase,5.53,10,Final,Hypertensive disorder,Atherosclerosis
Burneo et al. 2009,female sex,oral contraceptives,Increase,4.52,10,Final,Male,Uses oral contraception
"Khanevsky et al., 2019",female sex,depression,Increase,4.52,10,Final,Male,Depressive disorder_2.0
,female sex,first ischemic stroke,Decrease,4.43,10,Final,Male,Ischemic stroke_1.0
,female sex,second ischemic stroke,Decrease,4.43,10,Final,Male,Ischemic stroke_2.0
Bushnell et al. 2014,female sex,migraine with aura,Increase,4.43,10,Final,Male,Migraine with aura
Bushnell et al. 2014,migraine with aura,first ischemic stroke,Increase,4.43,10,Final,Migraine with aura,Ischemic stroke_1.0
Bushnell et al. 2014,migraine with aura,second ischemic stroke,Increase,3.84,10,Final,Migraine with aura,Ischemic stroke_2.0
Bushnell et al. 2014,female sex,arterial hypertension,Increase,3.84,10,Final,Male,Hypertensive disorder
Bushnell et al. 2014,oral contraceptives,second ischemic stroke,Increase,4.08,10,Final,Uses oral contraception,Ischemic stroke_2.0
Bushnell et al. 2014,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",second ischemic stroke,Increase,4.08,10,Final,Pre-eclampsia,Ischemic stroke_2.0
Bushnell et al. 2014,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",second ischemic stroke,Increase,4.08,10,Final,Hypertension complicating pregnancy,Ischemic stroke_2.0
Bushnell et al. 2014,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",second ischemic stroke,Increase,4.08,10,Final,Gestational diabetes mellitus complicating pregnancy,Ischemic stroke_2.0
Bushnell et al. 2014,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",first ischemic stroke,Increase,4.08,10,Final,Pre-eclampsia,Ischemic stroke_1.0
Bushnell et al. 2014,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",first ischemic stroke,Increase,4.08,10,Final,Hypertension complicating pregnancy,Ischemic stroke_1.0
Bushnell et al. 2014,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",first ischemic stroke,Increase,4.08,10,Final,Gestational diabetes mellitus complicating pregnancy,Ischemic stroke_1.0
Bushnell et al. 2014,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",arterial hypertension,Increase,4.08,10,Final,Pre-eclampsia,Hypertensive disorder
Bushnell et al. 2014,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",arterial hypertension,Increase,4.08,10,Final,Hypertension complicating pregnancy,Hypertensive disorder
Bushnell et al. 2014,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",arterial hypertension,Increase,4.08,10,Final,Gestational diabetes mellitus complicating pregnancy,Hypertensive disorder
Bushnell et al. 2014,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",Diabetes mellitus,Increase,4.08,10,Final,Pre-eclampsia,Diabetes mellitus
Bushnell et al. 2014,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",Diabetes mellitus,Increase,4.08,10,Final,Hypertension complicating pregnancy,Diabetes mellitus
Bushnell et al. 2014,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",Diabetes mellitus,Increase,4.08,10,Final,Gestational diabetes mellitus complicating pregnancy,Diabetes mellitus
Bushnell et al. 2014,female sex,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",Increase,6.84,10,Final,Male,Pre-eclampsia
Bushnell et al. 2014,female sex,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",Increase,6.84,10,Final,Male,Hypertension complicating pregnancy
Bushnell et al. 2014,female sex,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",Increase,6.84,10,Final,Male,Gestational diabetes mellitus complicating pregnancy
Bushnell et al. 2014,moderate physical activity,obesity,Decrease,6.84,10,Final,Exercises regularly,Obesity
Bushnell et al. 2014,healthy (mediterranean) diet,obesity,Decrease,6.84,10,Final,Mediterranean diet,Obesity
Bushnell et al. 2014,stroke severity (e.g. measured by NIHSS),death (all causes),Increase,6.84,10,Final,Assessment using National Institutes of Health stroke scale,Death
,first ischemic stroke,death (all causes),Increase,6.26,10,Final,Ischemic stroke_1.0,Death
,second ischemic stroke,death (all causes),Increase,6.26,10,Final,Ischemic stroke_2.0,Death
,depression,death (all causes),Increase,5.53,10,Final,Depressive disorder_2.0,Death
"Khanevski et al., 2019",moderate physical activity,migraine with aura,Decrease,4.17,10,Final,Exercises regularly,Migraine with aura
"Khanevski et al., 2019",healthy (mediterranean) diet,death (all causes),Decrease,5.42,10,Final,Mediterranean diet,Death
,obesity,death (all causes),Increase,5.42,10,Final,Obesity,Death
,Smoking,death (all causes),Increase,5.42,10,Final,Smoker,Death
"Bushnell et al., 2014",moderate physical activity,death (all causes),Decrease,5.42,10,Final,Exercises regularly,Death
"Bushnell et al., 2014",atrial fibrillation,death (all causes),Increase,5.42,10,Final,Atrial fibrillation,Death
"Bushnell et al., 2014",atrial fibrillation,stroke severity (e.g. measured by NIHSS),Increase,6.84,10,Final,Atrial fibrillation,Assessment using National Institutes of Health stroke scale
"Bushnell et al., 2014",atrial fibrillation,anticoagulation,Increase,6.84,10,Final,Atrial fibrillation,Anticoagulant therapy
"Goldstein et al., 2011",atherosclerosis,antiplatelet therapy (e.g. ASS),Increase,6.84,10,Final,Atherosclerosis,Platelet aggregation inhibitor therapy
"Goldstein et al., 2011",stenoses of cerebral vessels,antiplatelet therapy (e.g. ASS),Increase,6.84,10,Final,Stenosis,Platelet aggregation inhibitor therapy
,Smoking,atherosclerosis,Increase,6.84,10,Final,Smoker,Atherosclerosis
,Smoking,stenoses of cerebral vessels,Increase,6.84,10,Final,Smoker,Stenosis
,sleep apnea,arterial hypertension,Increase,4.52,10,Final,Sleep apnea,Hypertensive disorder
,Diabetes mellitus,arterial hypertension,Increase,4.52,10,Final,Diabetes mellitus,Hypertensive disorder
,low socioeconomic status,Smoking,Decrease,4.0,10,Final,Economic status,Smoker
,low socioeconomic status,arterial hypertension,Decrease,4.08,10,Final,Economic status,Hypertensive disorder
,low socioeconomic status,healthy (mediterranean) diet,Increase,4.08,10,Final,Economic status,Mediterranean diet
Marshall et al. 2015,low socioeconomic status,moderate physical activity,Increase,4.08,10,Final,Economic status,Exercises regularly
Marshall et al. 2015,low socioeconomic status,first ischemic stroke,Decrease,4.08,10,Final,Economic status,Ischemic stroke_1.0
Marshall et al. 2015,low socioeconomic status,second ischemic stroke,Decrease,4.08,10,Final,Economic status,Ischemic stroke_2.0
Marshall et al. 2015,low socioeconomic status,depression,Decrease,5.53,10,Final,Economic status,Depressive disorder_2.0
Marshall et al. 2015,cortical involvement or strategical localisation of stroke lesion,functional outcome (e.g. measured by mRS),Increase,5.53,10,Final,Lesion of brain,Assessment using Modified Rankin Scale
Marshall et al. 2015,cortical involvement or strategical localisation of stroke lesion,post stroke epilepsy,Increase,5.53,10,Final,Lesion of brain,Epilepsy due to cerebrovascular accident
Lorant et al. 2013,second ischemic stroke,functional outcome (e.g. measured by mRS),Increase,5.0,10,Final,Ischemic stroke_2.0,Assessment using Modified Rankin Scale
"Asplund et al, Stroke 2009",age,first ischemic stroke,Increase,6.0,11,Final,Age factor,Ischemic stroke_1.0
40:2319-2326,male sex,first ischemic stroke,Increase,5.0,11,Final,Male,Ischemic stroke_1.0
"Bushnell et al., JCBF2018",hypertension,first ischemic stroke,Increase,5.0,11,Final,Hypertensive disorder,Ischemic stroke_1.0
38: 2179–2191)postmenopausal vs premenopausal,metabolic syndrom,first ischemic stroke,Increase,6.0,11,Final,Metabolic syndrome X,Ischemic stroke_1.0
"Cipolla et al., JCBF2018",inflammation,first ischemic stroke,Increase,6.0,11,Final,Inflammation of specific body structures or tissue,Ischemic stroke_1.0
38:2129-2149,inflammation,blood-brain barrier breakdown,Decrease,6.0,11,Final,Inflammation of specific body structures or tissue,Blood-brain barrier
"includes diabetes, hyperlipoproteinemia, obesity (Sol M Rodriguez-Colon, stroke 2009",blood-brain barrier breakdown,first ischemic stroke,Decrease,6.0,11,Final,Blood-brain barrier,Ischemic stroke_1.0
40:200-205),metabolic syndrom,white matter hyperintensities (MRI),Increase,6.0,11,Final,Metabolic syndrome X,Leuko-araiosis
"Bernardo-Castro et al., Front Neurol 2020",white matter hyperintensities (MRI),first ischemic stroke,Increase,6.0,11,Final,Leuko-araiosis,Ischemic stroke_1.0
doi: 10.3389/fneur.2020.594672,exercise,first ischemic stroke,Decrease,0.51,11,Final,Exercises regularly,Ischemic stroke_1.0
"Bernardo-Castro et al., Front Neurol 2020",exercise,metabolic syndrom,Decrease,0.51,11,Final,Exercises regularly,Metabolic syndrome X
doi: 10.3389/fneur.2020.594672,exercise,hypertension,Decrease,0.51,11,Final,Exercises regularly,Hypertensive disorder
"Bernardo-Catro et al., 2020",hypertension,white matter hyperintensities (MRI),Increase,4.8,11,Final,Hypertensive disorder,Leuko-araiosis
"Frey et al, Front Neurol 2019",smoking,first ischemic stroke,Increase,5.31,11,Final,Smoker,Ischemic stroke_1.0
doi: 10.3389/fneur.2019.00238,smoking,white matter hyperintensities (MRI),Increase,5.0,11,Final,Smoker,Leuko-araiosis
"Ryu et al., Brain 2017 doi: 10.1093/brain/aww259",atherosclerosis,white matter hyperintensities (MRI),Increase,6.0,11,Final,Atherosclerosis,Leuko-araiosis
,metabolic syndrom,atherosclerosis,Increase,6.0,11,Final,Metabolic syndrome X,Atherosclerosis
,atherosclerosis/thrombosis,first ischemic stroke,Increase,6.0,11,Final,Thrombosis,Ischemic stroke_1.0
,atherosclerosis/thrombosis,first ischemic stroke,Increase,6.0,11,Final,Atherosclerosis,Ischemic stroke_1.0
,cardiac dysfunction,first ischemic stroke,Increase,6.0,11,Final,Disorder of cardiac function,Ischemic stroke_1.0
120 versus 135 systolic blood pressure,cardiac dysfunction,white matter hyperintensities (MRI),Increase,6.54,11,Final,Disorder of cardiac function,Leuko-araiosis
,atherosclerosis,vessel stenosis/occlusion,Increase,6.0,11,Final,Atherosclerosis,Complete obstruction
,atherosclerosis,vessel stenosis/occlusion,Increase,6.0,11,Final,Atherosclerosis,Stenosis
"Power et al., Neurology 2015",vessel stenosis/occlusion,white matter hyperintensities (MRI),Increase,6.13,11,Final,Complete obstruction,Leuko-araiosis
"Power et al., Neurology 2015",vessel stenosis/occlusion,white matter hyperintensities (MRI),Increase,6.13,11,Final,Stenosis,Leuko-araiosis
84:841-848,vessel stenosis/occlusion,first ischemic stroke,Increase,6.0,11,Final,Complete obstruction,Ischemic stroke_1.0
84:841-848,vessel stenosis/occlusion,first ischemic stroke,Increase,6.0,11,Final,Stenosis,Ischemic stroke_1.0
,atherosclerosis,vulnerable plaques,Increase,3.0,11,Final,Atherosclerosis,Complicated atheromatous plaque
"Sun et al., Sci Rep 2016 doi: 10.1038/srep33246",vulnerable plaques,first ischemic stroke,Increase,6.0,11,Final,Complicated atheromatous plaque,Ischemic stroke_1.0
"Famakin et al., Stroke 2009 doi: 10.1161/STROKEAHA.108.546150",vulnerable plaques,white matter hyperintensities (MRI),Increase,6.84,11,Final,Complicated atheromatous plaque,Leuko-araiosis
"myocardial infarction, coronary heart disease, cardiac failure Folsom et al., Stroke 2013",endarterectomy,vulnerable plaques,Decrease,1.0,11,Final,Endarterectomy,Complicated atheromatous plaque
44:961-967,endarterectomy,vessel stenosis/occlusion,Decrease,2.0,11,Final,Endarterectomy,Complete obstruction
44:961-967,endarterectomy,vessel stenosis/occlusion,Decrease,2.0,11,Final,Endarterectomy,Stenosis
"myocardial infarction, coronary heart disease, cardiac failure",kidney function,first ischemic stroke,Increase,3.0,11,Final,Finding of renal function,Ischemic stroke_1.0
"Hoshino et al., Jama Neurol 2018 doi: 10.1001/jamaneurol.2017.3960",kidney function,white matter hyperintensities (MRI),Increase,5.0,11,Final,Finding of renal function,Leuko-araiosis
,metabolic syndrom,kidney function,Increase,6.0,11,Final,Metabolic syndrome X,Finding of renal function
"Adams et al., Stroke 1993",enlarged perivascular spaces,first ischemic stroke,Increase,4.0,11,Final,Metadata,Ischemic stroke_1.0
24:35-41,microbleeds,white matter hyperintensities (MRI),Increase,6.0,11,Final,Silent micro-hemorrhage of brain,Leuko-araiosis
,preeclampsia/eclampsia,first ischemic stroke,Increase,6.84,11,Final,Pre-eclampsia,Ischemic stroke_1.0
,preeclampsia/eclampsia,first ischemic stroke,Increase,6.84,11,Final,Eclampsia,Ischemic stroke_1.0
"Kassem et al., Ann Transl Med 2020 doi: 10.21037/atm-2020-cass-16",race,first ischemic stroke,Increase,6.68,11,Final,Racial group,Ischemic stroke_1.0
,preeclampsia/eclampsia,hypertension,Increase,6.0,11,Final,Pre-eclampsia,Hypertensive disorder
,preeclampsia/eclampsia,hypertension,Increase,6.0,11,Final,Eclampsia,Hypertensive disorder
"Cochrane Database Syst Rev. 2020, doi: 10.1002/14651858.CD000515.pub",genetic factors,first ischemic stroke,Increase,5.53,11,Final,Genetic predisposition,Ischemic stroke_1.0
,inflammation,white matter hyperintensities (MRI),Increase,6.13,11,Final,Inflammation of specific body structures or tissue,Leuko-araiosis
"Kelley et al., Stroke 2020 doi: 10.1161/STROKEAHA.120.030045",infection,first ischemic stroke,Increase,5.2,11,Final,Infectious disease,Ischemic stroke_1.0
"Kim et al., Sci Rep 2019 doi: 10.1038/s41598-019-45109-y",infection,inflammation,Increase,5.42,11,Final,Infectious disease,Inflammation of specific body structures or tissue
,inflammation,coagulopathy,Increase,5.42,11,Final,Inflammation of specific body structures or tissue,Hypercoagulability state
"Ballerini et al., Neuroimage Clin 2020 doi: 10.1016/j.nicl.2019.102120",coagulopathy,first ischemic stroke,Increase,6.84,11,Final,Hypercoagulability state,Ischemic stroke_1.0
,first ischemic stroke,second ischemic stroke,Increase,6.39,13,Draft,Ischemic stroke_1.0,Ischemic stroke_2.0
,atherosclerosis,first ischemic stroke,Increase,5.0,13,Draft,Atherosclerosis,Ischemic stroke_1.0
,atherosclerosis,second ischemic stroke,Increase,5.0,13,Draft,Atherosclerosis,Ischemic stroke_2.0
,atrial fibrillation,second ischemic stroke,Increase,4.26,13,Draft,Atrial fibrillation,Ischemic stroke_2.0
,atrial fibrillation,first ischemic stroke,Increase,4.26,13,Draft,Atrial fibrillation,Ischemic stroke_1.0
,cancer,first ischemic stroke,Increase,4.08,13,Draft,Malignant neoplastic disease,Ischemic stroke_1.0
,vaskulitis,first ischemic stroke,Increase,5.2,13,Draft,Vasculitis,Ischemic stroke_1.0
,vaskulitis,second ischemic stroke,Increase,5.2,13,Draft,Vasculitis,Ischemic stroke_2.0
,cancer,second ischemic stroke,Increase,5.2,13,Draft,Malignant neoplastic disease,Ischemic stroke_2.0
,chemotherapy,first ischemic stroke,Increase,5.2,13,Draft,Chemotherapy,Ischemic stroke_1.0
,chemotherapy,second ischemic stroke,Increase,5.2,13,Draft,Chemotherapy,Ischemic stroke_2.0
,cancer,chemotherapy,Increase,5.2,13,Draft,Malignant neoplastic disease,Chemotherapy
,sinus venous thrombosis,first ischemic stroke,Increase,5.2,13,Draft,Cerebral venous sinus thrombosis,Ischemic stroke_1.0
,sinus venous thrombosis,second ischemic stroke,Increase,5.2,13,Draft,Cerebral venous sinus thrombosis,Ischemic stroke_2.0
,age,second ischemic stroke,Increase,5.2,13,Draft,Age factor,Ischemic stroke_2.0
,age,first ischemic stroke,Increase,5.2,13,Draft,Age factor,Ischemic stroke_1.0
,age,atherosclerosis,Increase,5.2,13,Draft,Age factor,Atherosclerosis
,smoking,atherosclerosis,Increase,5.2,13,Draft,Smoker,Atherosclerosis
,smoking,first ischemic stroke,Increase,5.2,13,Draft,Smoker,Ischemic stroke_1.0
,smoking,second ischemic stroke,Increase,5.2,13,Draft,Smoker,Ischemic stroke_2.0
,dyslipidemia,second ischemic stroke,Increase,5.2,13,Draft,Dyslipidemia,Ischemic stroke_2.0
,dyslipidemia,first ischemic stroke,Increase,5.2,13,Draft,Dyslipidemia,Ischemic stroke_1.0
,dyslipidemia,atherosclerosis,Increase,5.2,13,Draft,Dyslipidemia,Atherosclerosis
,diabetes,atherosclerosis,Increase,5.2,13,Draft,Diabetes mellitus,Atherosclerosis
,diabetes,first ischemic stroke,Increase,5.2,13,Draft,Diabetes mellitus,Ischemic stroke_1.0
,diabetes,second ischemic stroke,Increase,5.2,13,Draft,Diabetes mellitus,Ischemic stroke_2.0
,age,atrial fibrillation,Increase,4.08,13,Draft,Age factor,Atrial fibrillation
,age,cancer,Increase,4.08,13,Draft,Age factor,Malignant neoplastic disease
,female gender,sinus venous thrombosis,Increase,4.08,13,Draft,Male,Cerebral venous sinus thrombosis
,male gender,first ischemic stroke,Increase,4.08,13,Draft,Male,Ischemic stroke_1.0
,male gender,second ischemic stroke,Increase,4.08,13,Draft,Male,Ischemic stroke_2.0
,pregnancy,sinus venous thrombosis,Increase,4.08,13,Draft,Pregnancy,Cerebral venous sinus thrombosis
,female gender,pregnancy,Increase,6.84,13,Draft,Male,Pregnancy
,first ischemic stroke,disability,Increase,6.84,13,Draft,Ischemic stroke_1.0,Disability
,second ischemic stroke,disability,Increase,6.84,13,Draft,Ischemic stroke_2.0,Disability
,cancer,disability,Increase,6.84,13,Draft,Malignant neoplastic disease,Disability
,vaskulitis,disability,Increase,6.84,13,Draft,Vasculitis,Disability
,diabetes,disability,Increase,6.84,13,Draft,Diabetes mellitus,Disability
,arterial hypertension,atherosclerosis,Increase,5.1,13,Draft,Hypertensive disorder,Atherosclerosis
,arterial hypertension,first ischemic stroke,Increase,5.1,13,Draft,Hypertensive disorder,Ischemic stroke_1.0
,arterial hypertension,second ischemic stroke,Increase,5.1,13,Draft,Hypertensive disorder,Ischemic stroke_2.0
,arterial hypertension,disability,Increase,5.1,13,Draft,Hypertensive disorder,Disability
,age,arterial hypertension,Increase,5.1,13,Draft,Age factor,Hypertensive disorder
,smoking,arterial hypertension,Increase,5.1,13,Draft,Smoker,Hypertensive disorder
,pregnancy,diabetes,Increase,5.1,13,Draft,Pregnancy,Diabetes mellitus
,first ischemic stroke,depression,Increase,5.1,13,Draft,Ischemic stroke_1.0,Depressive disorder_2.0
,second ischemic stroke,depression,Increase,5.1,13,Draft,Ischemic stroke_2.0,Depressive disorder_2.0
,cancer,depression,Increase,5.1,13,Draft,Malignant neoplastic disease,Depressive disorder_2.0
,first ischemic stroke,cognitive decline,Increase,5.1,13,Draft,Ischemic stroke_1.0,Impaired cognition
,second ischemic stroke,cognitive decline,Increase,5.1,13,Draft,Ischemic stroke_2.0,Impaired cognition
,second ischemic stroke,qualitiy of life,Decrease,5.1,13,Draft,Ischemic stroke_2.0,Quality of life satisfaction
,first ischemic stroke,qualitiy of life,Decrease,5.1,13,Draft,Ischemic stroke_1.0,Quality of life satisfaction
,depression,qualitiy of life,Decrease,5.1,13,Draft,Depressive disorder_2.0,Quality of life satisfaction
,diabetes,qualitiy of life,Decrease,5.1,13,Draft,Diabetes mellitus,Quality of life satisfaction
,vaskulitis,qualitiy of life,Decrease,5.1,13,Draft,Vasculitis,Quality of life satisfaction
,disability,qualitiy of life,Decrease,5.1,13,Draft,Disability,Quality of life satisfaction
,pregnancy,depression,Increase,5.1,13,Draft,Pregnancy,Depressive disorder_2.0
,first ischemic stroke,mobility,Increase,5.1,13,Draft,Ischemic stroke_1.0,Impaired mobility
,second ischemic stroke,mobility,Increase,2.65,13,Draft,Ischemic stroke_2.0,Impaired mobility
,disability,mobility,Increase,2.65,13,Draft,Disability,Impaired mobility
,depression,mobility,Increase,2.65,13,Draft,Depressive disorder_2.0,Impaired mobility
,cancer,qualitiy of life,Decrease,2.65,13,Draft,Malignant neoplastic disease,Quality of life satisfaction
,age,mobility,Increase,3.0,13,Draft,Age factor,Impaired mobility
,pregnancy,mobility,Increase,0.57,13,Draft,Pregnancy,Impaired mobility
,endocarditis,first ischemic stroke,Increase,0.57,13,Draft,Endocarditis,Ischemic stroke_1.0
,endocarditis,second ischemic stroke,Increase,0.57,13,Draft,Endocarditis,Ischemic stroke_2.0
,endocarditis,second ischemic stroke,Increase,5.1,13,Draft,Endocarditis,Ischemic stroke_2.0
,endocarditis,disability,Increase,5.1,13,Draft,Endocarditis,Disability
,persistent foramen ovale,first ischemic stroke,Increase,5.64,13,Draft,Patent foramen ovale,Ischemic stroke_1.0
,persistent foramen ovale,second ischemic stroke,Increase,5.64,13,Draft,Patent foramen ovale,Ischemic stroke_2.0
,hypercoagulability,first ischemic stroke,Increase,4.61,13,Draft,Hypercoagulability state,Ischemic stroke_1.0
,hypercoagulability,second ischemic stroke,Increase,4.61,13,Draft,Hypercoagulability state,Ischemic stroke_2.0
,hypercoagulability,sinus venous thrombosis,Increase,4.61,13,Draft,Hypercoagulability state,Cerebral venous sinus thrombosis
,cancer,hypercoagulability,Increase,4.61,13,Draft,Malignant neoplastic disease,Hypercoagulability state
,pregnancy,hypercoagulability,Increase,4.61,13,Draft,Pregnancy,Hypercoagulability state
,smoking,hypercoagulability,Increase,3.0,13,Draft,Smoker,Hypercoagulability state
,malformations,first ischemic stroke,Increase,1.4,13,Draft,Congenital malformation,Ischemic stroke_1.0
,malformations,second ischemic stroke,Increase,1.4,13,Draft,Congenital malformation,Ischemic stroke_2.0
,endovascular interventions,first ischemic stroke,Increase,5.88,13,Draft,Percutaneous transluminal procedure on blood vessel,Ischemic stroke_1.0
,endovascular interventions,second ischemic stroke,Increase,5.88,13,Draft,Percutaneous transluminal procedure on blood vessel,Ischemic stroke_2.0
,atherosclerosis,endovascular interventions,Increase,5.88,13,Draft,Atherosclerosis,Percutaneous transluminal procedure on blood vessel
,endocarditis,endovascular interventions,Increase,1.69,13,Draft,Endocarditis,Percutaneous transluminal procedure on blood vessel
,pregnancy,chemotherapy,Decrease,3.14,13,Draft,Pregnancy,Chemotherapy
,neurosurgery,first ischemic stroke,Increase,3.14,13,Draft,Surgical procedure,Ischemic stroke_1.0
,neurosurgery,second ischemic stroke,Increase,4.34,13,Draft,Surgical procedure,Ischemic stroke_2.0
,cancer,neurosurgery,Increase,4.34,13,Draft,Malignant neoplastic disease,Surgical procedure
,malformations,neurosurgery,Increase,3.14,13,Draft,Congenital malformation,Surgical procedure
,migraine,ischemic stroke,Increase,4.17,14,Draft,Migraine,Ischemic stroke
,migraine,smoking,Decrease,4.52,14,Draft,Migraine,Smoker
,obesity,ischemic stroke,Increase,6.0,14,Draft,Obesity,Ischemic stroke
,hypertension,large artery atherosclerosis,Increase,6.0,14,Draft,Hypertensive disorder,Atherosclerosis
,obesity,hypertension,Increase,6.84,14,Draft,Obesity,Hypertensive disorder
,low blood pressure,decreased systemic perfusion,Increase,6.84,14,Draft,Low blood pressure,Organ or tissue vascular perfusion decreased
,heart failure,decreased systemic perfusion,Increase,6.84,14,Draft,Heart failure,Organ or tissue vascular perfusion decreased
,loss of blood,decreased systemic perfusion,Increase,6.84,14,Draft,Bleeding,Organ or tissue vascular perfusion decreased
,reduction or complete blockage of blood flow,ischemic stroke,Increase,6.84,14,Draft,Decreased vascular flow,Ischemic stroke
,decreased systemic perfusion,reduction or complete blockage of blood flow,Increase,6.84,14,Draft,Organ or tissue vascular perfusion decreased,Decreased vascular flow
,severe stenosis,reduction or complete blockage of blood flow,Increase,6.84,14,Draft,Stenosis,Decreased vascular flow
,occlusion of a blood vessel,reduction or complete blockage of blood flow,Increase,6.84,14,Draft,Complete obstruction,Decreased vascular flow
,arterial dissection,ischemic stroke,Increase,6.84,14,Draft,Dissection of artery,Ischemic stroke
,COVID-19,ischemic stroke,Increase,6.84,14,Draft,COVID-19,Ischemic stroke
,fibromuscular dysplasia,ischemic stroke,Increase,6.84,14,Draft,Fibromuscular dysplasia,Ischemic stroke
,vasculitis,ischemic stroke,Increase,6.84,14,Draft,Vasculitis,Ischemic stroke
,Moyamoya disease,ischemic stroke,Increase,6.84,14,Draft,Moyamoya disease,Ischemic stroke
,sickle cell disease arteriopathy,ischemic stroke,Increase,6.84,14,Draft,Sickling disorder due to hemoglobin S,Ischemic stroke
,ischemic stroke,production of reactive oxygen species,Increase,6.84,14,Draft,Ischemic stroke,Visit
,production of reactive oxygen species,DNA damage,Increase,6.84,14,Draft,Visit,DNA damage
,ischemic stroke,loss of brain structural integrity,Increase,6.84,14,Draft,Ischemic stroke,Visit type
,female sex steroids,migraine,Increase,6.84,14,Draft,Female sex hormones - serum level - finding,Migraine
,female sex steroids,COVID-19,Decrease,3.37,14,Draft,Female sex hormones - serum level - finding,COVID-19
,large artery atherosclerosis,ischemic stroke,Increase,6.84,14,Draft,Atherosclerosis,Ischemic stroke
,ageing,DNA damage,Increase,6.84,14,Draft,Age factor,DNA damage
,ageing,migraine,Decrease,6.84,14,Draft,Age factor,Migraine
,ageing,hypertension,Increase,6.84,14,Draft,Age factor,Hypertensive disorder
,production of reactive oxygen species,endothelial dysfunction,Increase,6.84,14,Draft,Visit,Cardiac syndrome X
,hypercholesterolemia,endothelial dysfunction,Increase,6.84,14,Draft,Hypercholesterolemia,Cardiac syndrome X
,smoking,endothelial dysfunction,Increase,6.84,14,Draft,Smoker,Cardiac syndrome X
,diabetes mellitus,endothelial dysfunction,Increase,6.84,14,Draft,Diabetes mellitus,Cardiac syndrome X
,hypertension,endothelial dysfunction,Increase,6.84,14,Draft,Hypertensive disorder,Cardiac syndrome X
"Harrison Internal Med., 2020",Embolism,First Ischemic Stroke,Increase,6.0,16,Final,Embolism,Ischemic stroke_1.0
"Harrison Internal Med., 2020",Thrombosis,First Ischemic Stroke,Increase,4.61,16,Final,Thrombosis,Ischemic stroke_1.0
"Harrison Internal Med., 2020",Lacunes,Thrombosis,Increase,4.61,16,Final,Lacunar infarction,Thrombosis
"Harrison Internal Med., 2020",Atrial Fibrillation,Embolism,Increase,4.61,16,Final,Atrial fibrillation,Embolism
"Harrison Internal Med., 2020",Atherosclerosis,Thrombosis,Increase,4.61,16,Final,Atherosclerosis,Thrombosis
"Harrison Internal Med., 2020",Male Sex,Atherosclerosis,Increase,4.61,16,Final,Male,Atherosclerosis
"Harrison Internal Med., 2020",Age,Atherosclerosis,Increase,4.61,16,Final,Age factor,Atherosclerosis
"Harrison Internal Med., 2020",Smoking,Atherosclerosis,Increase,4.61,16,Final,Smoker,Atherosclerosis
"Harrison Internal Med., 2020",Diabetes,Atherosclerosis,Increase,4.61,16,Final,Diabetes mellitus,Atherosclerosis
"Harrison Internal Med., 2020",Dyslipidemia,Atherosclerosis,Increase,4.0,16,Final,Dyslipidemia,Atherosclerosis
"Harrison Internal Med., 2020",Hypertension,Atherosclerosis,Increase,4.61,16,Final,Hypertensive disorder,Atherosclerosis
"Harrison Internal Med., 2020",Arterial Dissection,First Ischemic Stroke,Increase,4.61,16,Final,Dissection of artery,Ischemic stroke_1.0
"Harrison Internal Med., 2020",Hypertension,Lacunes,Increase,4.61,16,Final,Hypertensive disorder,Lacunar infarction
"Harrison Internal Med., 2020",Age,Lacunes,Increase,4.61,16,Final,Age factor,Lacunar infarction
"Harrison Internal Med., 2020",Hypercoagulopathy,Thrombosis,Increase,4.61,16,Final,Hypercoagulability state,Thrombosis
"Harrison Internal Med., 2020",Vasculitis,First Ischemic Stroke,Increase,4.61,16,Final,Vasculitis,Ischemic stroke_1.0
,Cardiac Remodelling,Atrial Fibrillation,Increase,4.61,16,Final,Death type,Atrial fibrillation
,Age,Cardiac Remodelling,Increase,4.61,16,Final,Age factor,Death type
,Hypertension,Cardiac Remodelling,Increase,4.61,16,Final,Hypertensive disorder,Death type
,Other Cardiac Pathologies,Cardiac Remodelling,Increase,4.61,16,Final,Other Cardiac Pathologies,Death type
,Atherosclerosis,Other Cardiac Pathologies,Increase,4.61,16,Final,Atherosclerosis,Other Cardiac Pathologies
"Harrison Internal Med., 2020",Atherosclerosis,Myocardial Infarction,Increase,4.61,16,Final,Atherosclerosis,Myocardial infarction
,Myocardial Infarction,Cardiac Remodelling,Increase,4.61,16,Final,Myocardial infarction,Death type
"Harrison Internal Med., 2020",Second-hand Smoking,Atherosclerosis,Increase,4.61,16,Final,Passive smoker,Atherosclerosis
,Insulin Resistance / Impaired glucose metabolism,Diabetes,Increase,4.0,16,Final,Insulin resistance,Diabetes mellitus
,Insulin Resistance / Impaired glucose metabolism,Diabetes,Increase,4.0,16,Final,Disorder of glucose metabolism,Diabetes mellitus
"Kernan, 2002",Insulin Resistance / Impaired glucose metabolism,Atherosclerosis,Increase,4.0,16,Final,Insulin resistance,Atherosclerosis
"Kernan, 2002",Insulin Resistance / Impaired glucose metabolism,Atherosclerosis,Increase,4.0,16,Final,Disorder of glucose metabolism,Atherosclerosis
"Kernan, 2002",Age,Insulin Resistance / Impaired glucose metabolism,Increase,4.0,16,Final,Age factor,Insulin resistance
"Kernan, 2002",Age,Insulin Resistance / Impaired glucose metabolism,Increase,4.0,16,Final,Age factor,Disorder of glucose metabolism
,Physical Inactivity,Obesity,Increase,4.61,16,Final,Gets no exercise,Obesity
Kernan et al. 2002,Insulin Resistance / Impaired glucose metabolism,Hypertension,Increase,4.0,16,Final,Insulin resistance,Hypertensive disorder
Kernan et al. 2002,Insulin Resistance / Impaired glucose metabolism,Hypertension,Increase,4.0,16,Final,Disorder of glucose metabolism,Hypertensive disorder
Kernan et al 2002,Insulin Resistance / Impaired glucose metabolism,Dyslipidemia,Increase,2.0,16,Final,Insulin resistance,Dyslipidemia
Kernan et al 2002,Insulin Resistance / Impaired glucose metabolism,Dyslipidemia,Increase,2.0,16,Final,Disorder of glucose metabolism,Dyslipidemia
Kernan et al 2002,Insulin Resistance / Impaired glucose metabolism,Inflammation,Increase,4.0,16,Final,Insulin resistance,Inflammation of specific body structures or tissue
Kernan et al 2002,Insulin Resistance / Impaired glucose metabolism,Inflammation,Increase,4.0,16,Final,Disorder of glucose metabolism,Inflammation of specific body structures or tissue
"Hansson , 2006",Inflammation,Atherosclerosis,Increase,4.17,16,Final,Inflammation of specific body structures or tissue,Atherosclerosis
Kahn et. al 2006,Obesity,Insulin Resistance / Impaired glucose metabolism,Increase,4.0,16,Final,Obesity,Insulin resistance
Kahn et. al 2006,Obesity,Insulin Resistance / Impaired glucose metabolism,Increase,4.0,16,Final,Obesity,Disorder of glucose metabolism
Kahn et. al 2006,Obesity,Inflammation,Increase,4.17,16,Final,Obesity,Inflammation of specific body structures or tissue
"Hering, 2015",Psychogenic Stress,Sympathetic activation,Increase,0.51,16,Final,Stress,Route
"Hering, 2015",Sympathetic activation,Thrombosis,Increase,0.51,16,Final,Route,Thrombosis
Redline et al 2011,Sleep disturbances / Obstructive Sleep Apnea,Hypertension,Increase,0.51,16,Final,Sleep apnea,Hypertensive disorder
Redline et al 2011,Sleep disturbances / Obstructive Sleep Apnea,Hypertension,Increase,0.51,16,Final,Dyssomnia,Hypertensive disorder
Redline et al 2011,Sleep disturbances / Obstructive Sleep Apnea,Insulin Resistance / Impaired glucose metabolism,Increase,2.68,16,Final,Sleep apnea,Insulin resistance
Redline et al 2011,Sleep disturbances / Obstructive Sleep Apnea,Insulin Resistance / Impaired glucose metabolism,Increase,2.68,16,Final,Sleep apnea,Disorder of glucose metabolism
Redline et al 2011,Sleep disturbances / Obstructive Sleep Apnea,Insulin Resistance / Impaired glucose metabolism,Increase,2.68,16,Final,Dyssomnia,Insulin resistance
Redline et al 2011,Sleep disturbances / Obstructive Sleep Apnea,Insulin Resistance / Impaired glucose metabolism,Increase,2.68,16,Final,Dyssomnia,Disorder of glucose metabolism
Redline et al 2011,Sleep disturbances / Obstructive Sleep Apnea,Inflammation,Increase,1.4,16,Final,Sleep apnea,Inflammation of specific body structures or tissue
Redline et al 2011,Sleep disturbances / Obstructive Sleep Apnea,Inflammation,Increase,1.4,16,Final,Dyssomnia,Inflammation of specific body structures or tissue
,Psychogenic Stress,Smoking,Increase,2.68,16,Final,Stress,Smoker
,Insulin Resistance / Impaired glucose metabolism,Prediabetes,Increase,2.68,16,Final,Insulin resistance,Prediabetes
,Insulin Resistance / Impaired glucose metabolism,Prediabetes,Increase,2.68,16,Final,Disorder of glucose metabolism,Prediabetes
Fonville et al. 2014,Prediabetes,Diabetes,Increase,2.68,16,Final,Prediabetes,Diabetes mellitus
,Hypertension,Arterial Dissection,Increase,2.68,16,Final,Hypertensive disorder,Dissection of artery
,Smoking,Hypertension,Increase,2.68,16,Final,Smoker,Hypertensive disorder
American Heart Association 2014,Antihypertensive Therapy,Hypertension,Decrease,4.61,16,Final,Antihypertensive therapy,Hypertensive disorder
American Heart Association 2014,Statin Therapy,Dyslipidemia,Decrease,4.61,16,Final,Administration of prophylactic statin,Dyslipidemia
Hansson 2006,Statin Therapy,Inflammation,Decrease,3.44,16,Final,Administration of prophylactic statin,Inflammation of specific body structures or tissue
Kernan et al 2002,Weight Loss and Aerobic Exercise,Insulin Resistance / Impaired glucose metabolism,Decrease,3.44,16,Final,Exercises regularly,Insulin resistance
Kernan et al 2002,Weight Loss and Aerobic Exercise,Insulin Resistance / Impaired glucose metabolism,Decrease,3.44,16,Final,Exercises regularly,Disorder of glucose metabolism
Kernan et al 2002,Weight Loss and Aerobic Exercise,Insulin Resistance / Impaired glucose metabolism,Decrease,3.44,16,Final,Weight loss,Insulin resistance
Kernan et al 2002,Weight Loss and Aerobic Exercise,Insulin Resistance / Impaired glucose metabolism,Decrease,3.44,16,Final,Weight loss,Disorder of glucose metabolism
American Heart Association 2014,Dietary salt restriction,Hypertension,Decrease,3.44,16,Final,Low sodium diet,Hypertensive disorder
American Heart Association 2014,Weight Loss and Aerobic Exercise,Physical Inactivity,Decrease,2.68,16,Final,Exercises regularly,Gets no exercise
American Heart Association 2014,Weight Loss and Aerobic Exercise,Physical Inactivity,Decrease,2.68,16,Final,Weight loss,Gets no exercise
American Heart Association 2014,Healthy Diet,Obesity,Decrease,2.68,16,Final,Healthy diet,Obesity
American Heart Association 2014,Glycemic control,Diabetes,Decrease,2.68,16,Final,Blood glucose management,Diabetes mellitus
Kernan et al 2002,Thiazolidindione,Dyslipidemia,Decrease,2.25,16,Final,Thiazolidinedione,Dyslipidemia
Kernan et al 2002,Thiazolidindione,Hypertension,Decrease,2.25,16,Final,Thiazolidinedione,Hypertensive disorder
Kernan et al 2002,Thiazolidindione,Insulin Resistance / Impaired glucose metabolism,Decrease,2.25,16,Final,Thiazolidinedione,Insulin resistance
Kernan et al 2002,Thiazolidindione,Insulin Resistance / Impaired glucose metabolism,Decrease,2.25,16,Final,Thiazolidinedione,Disorder of glucose metabolism
American Diabetes Association 2020,SGLT2 Inhibitors,Diabetes,Decrease,2.25,16,Final,Sodium glucose cotransporter subtype 2 inhibitor,Diabetes mellitus
American Diabetes Association 2020,GLP1 Receptor Agonists,Diabetes,Decrease,2.25,16,Final,Glucagon-like peptide 1 receptor agonist,Diabetes mellitus
American Heart Association 2014,CPAP Treatment,Sleep disturbances / Obstructive Sleep Apnea,Decrease,2.25,16,Final,Continuous positive airway pressure ventilation treatment,Sleep apnea
American Heart Association 2014,CPAP Treatment,Sleep disturbances / Obstructive Sleep Apnea,Decrease,2.25,16,Final,Continuous positive airway pressure ventilation treatment,Dyssomnia
American Heart Association 2014,Smoking Cessation,Smoking,Decrease,2.25,16,Final,Smoking cessation therapy,Smoker
American Heart Association 2014,Carotid Endarterectomy / Angioplasty / stenting,Atherosclerosis,Decrease,3.07,16,Final,Carotid endarterectomy,Atherosclerosis
American Heart Association 2014,Carotid Endarterectomy / Angioplasty / stenting,Atherosclerosis,Decrease,3.07,16,Final,Angioplasty of carotid artery,Atherosclerosis
American Heart Association 2014,Carotid Endarterectomy / Angioplasty / stenting,Atherosclerosis,Decrease,3.07,16,Final,Insertion of carotid artery stent,Atherosclerosis
American Heart Association 2014,Mono-/Dual Antiplatelet Therapy,Thrombosis,Decrease,3.0,16,Final,Platelet aggregation inhibitor therapy,Thrombosis
American Heart Association 2014,Anticoagulation Therapy,Embolism,Decrease,3.07,16,Final,Anticoagulant therapy,Embolism
American Heart Association 2014,Mono-/Dual Antiplatelet Therapy,Arterial Dissection,Decrease,2.68,16,Final,Platelet aggregation inhibitor therapy,Dissection of artery
American Heart Association 2014,Anticoagulation Therapy,Arterial Dissection,Decrease,2.68,16,Final,Anticoagulant therapy,Dissection of artery
American Heart Association 2014,Anticoagulation Therapy,Hypercoagulopathy,Decrease,2.68,16,Final,Anticoagulant therapy,Hypercoagulability state
Harrison internal medicine 2020,Statin Therapy,Thrombosis,Decrease,2.68,16,Final,Administration of prophylactic statin,Thrombosis
Harrison internal medicine 2020,Statin Therapy,Hypertension,Decrease,2.68,16,Final,Administration of prophylactic statin,Hypertensive disorder
Sundell 2008 & mostofsky 2016,Low-Moderate Alcohol Consumption,Atherosclerosis,Decrease,2.0,16,Final,Moderate drinker,Atherosclerosis
Sundell 2008 & mostofsky 2016,Heavy Alcohol Consumption,Hypertension,Increase,2.0,16,Final,Heavy drinker,Hypertensive disorder
Sundell 2008 & mostofsky 2016,Heavy Alcohol Consumption,Other Cardiac Pathologies,Increase,2.0,16,Final,Heavy drinker,Other Cardiac Pathologies
Sundell 2008 & mostofsky 2016,Heavy Alcohol Consumption,Atrial Fibrillation,Increase,2.0,16,Final,Heavy drinker,Atrial fibrillation
Sundell 2008 & mostofsky 2016,Heavy Alcohol Consumption,Thrombosis,Increase,2.0,16,Final,Heavy drinker,Thrombosis
American Heart Association 2014,Reducing Alcohol Consumption,Heavy Alcohol Consumption,Decrease,2.0,16,Final,Decreased alcohol consumption,Heavy drinker
,First Ischemic Stroke,Neurological Sequalae,Increase,2.68,16,Final,Ischemic stroke_1.0,Sequelae of neurological disorders
,First Ischemic Stroke,Death,Increase,2.68,16,Final,Ischemic stroke_1.0,Death
,First Ischemic Stroke,Recurrent Stroke,Increase,2.68,16,Final,Ischemic stroke_1.0,Ischemic stroke_2.0
Dirnagl Review,first stroke,cerebral inflammation,Increase,6.0,17,Draft,Ischemic stroke_1.0,Encephalitis
Dirnagl Review,systemic inflammation,first stroke,Increase,6.84,17,Draft,Systemic inflammatory response syndrome,Ischemic stroke_1.0
Meisel Review NEJM/Nature,first stroke,peripheral immune competence,Decrease,6.84,17,Draft,Ischemic stroke_1.0,Domain
,first stroke,large infarction,Increase,6.84,19,Draft,Ischemic stroke_1.0,Cerebral infarction
,first stroke,pneumonia,Increase,6.84,19,Draft,Ischemic stroke_1.0,Pneumonia
,large infarction,pneumonia,Increase,6.84,19,Draft,Cerebral infarction,Pneumonia
,pneumonia,death,Increase,6.84,19,Draft,Pneumonia,Death
,first stroke,death,Increase,6.84,19,Draft,Ischemic stroke_1.0,Death
,first stroke,second stroke,Increase,6.84,19,Draft,Ischemic stroke_1.0,Ischemic stroke_2.0
,second stroke,pneumonia,Increase,6.84,19,Draft,Ischemic stroke_2.0,Pneumonia
,second stroke,death,Increase,6.84,19,Draft,Ischemic stroke_2.0,Death
,first stroke,depression,Increase,6.84,19,Draft,Ischemic stroke_1.0,Depressive disorder_2.0
,depression,immobility,Decrease,6.84,19,Draft,Depressive disorder_2.0,Impaired mobility_2.0
,immobility,pneumonia,Decrease,6.84,19,Draft,Impaired mobility_2.0,Pneumonia
,first stroke,immobility,Decrease,6.84,19,Draft,Ischemic stroke_1.0,Impaired mobility_2.0
,immobility,death,Decrease,6.84,19,Draft,Impaired mobility_2.0,Death
,first stroke,cognitive decline,Increase,6.84,19,Draft,Ischemic stroke_1.0,Impaired cognition
,pneumonia,cognitive decline,Increase,5.1,19,Draft,Pneumonia,Impaired cognition
,cognitive decline,death,Increase,2.79,19,Draft,Impaired cognition,Death
,second stroke,cognitive decline,Increase,2.79,19,Draft,Ischemic stroke_2.0,Impaired cognition
,hypertension,first stroke,Increase,6.84,19,Draft,Hypertensive disorder,Ischemic stroke_1.0
,hypertension,second stroke,Increase,6.84,19,Draft,Hypertensive disorder,Ischemic stroke_2.0
,hypertension,cognitive decline,Increase,5.31,19,Draft,Hypertensive disorder,Impaired cognition
,first stroke,infarct localisation,Increase,6.84,19,Draft,Ischemic stroke_1.0,Cerebral infarction
,infarct localisation,cognitive decline,Increase,6.84,19,Draft,Cerebral infarction,Impaired cognition
,infarct localisation,immunodepression,Increase,6.84,19,Draft,Cerebral infarction,Immunosuppression
,immunodepression,pneumonia,Increase,6.84,19,Draft,Immunosuppression,Pneumonia
,immunodepression,cognitive decline,Decrease,0.51,19,Draft,Immunosuppression,Impaired cognition
,diabetes mellitus,second stroke,Increase,6.84,19,Draft,Diabetes mellitus,Ischemic stroke_2.0
,diabetes mellitus,first stroke,Increase,6.84,19,Draft,Diabetes mellitus,Ischemic stroke_1.0
,diabetes mellitus,cognitive decline,Increase,4.61,19,Draft,Diabetes mellitus,Impaired cognition
,first stroke,spasticity,Increase,6.84,19,Draft,Ischemic stroke_1.0,Spasticity
,second stroke,spasticity,Increase,6.84,19,Draft,Ischemic stroke_2.0,Spasticity
,spasticity,immobility,Decrease,6.84,19,Draft,Spasticity,Impaired mobility_2.0
,spasticity,pain,Increase,6.84,19,Draft,Spasticity,Pain
,pain,immobility,Decrease,6.84,19,Draft,Pain,Impaired mobility_2.0
,female,large infarction,Decrease,4.8,19,Draft,Male,Cerebral infarction
,depression,female,Decrease,4.8,19,Draft,Depressive disorder_2.0,Male
,large infarction,severe disability,Increase,6.84,19,Draft,Cerebral infarction,Disability
,severe disability,immobility,Decrease,6.84,19,Draft,Disability,Impaired mobility_2.0
,first stroke,dysphagia,Increase,6.84,19,Draft,Ischemic stroke_1.0,Dysphagia
,second stroke,dysphagia,Increase,6.84,19,Draft,Ischemic stroke_2.0,Dysphagia
,dysphagia,pneumonia,Increase,6.84,19,Draft,Dysphagia,Pneumonia
,dysphagia,malnutrition,Increase,6.84,19,Draft,Dysphagia,Nutritional disorder
,first stroke,cachexia,Increase,4.8,19,Draft,Ischemic stroke_1.0,Cachexia
,second stroke,cachexia,Increase,4.34,19,Draft,Ischemic stroke_2.0,Cachexia
,malnutrition,cachexia,Increase,6.84,19,Draft,Nutritional disorder,Cachexia
,cachexia,death,Increase,4.8,19,Draft,Cachexia,Death
,malnutrition,death,Increase,3.14,19,Draft,Nutritional disorder,Death
,immobility,reduced QoL/ADL,Increase,6.84,19,Draft,Impaired mobility_2.0,Quality of life satisfaction
,spasticity,reduced QoL/ADL,Decrease,6.84,19,Draft,Spasticity,Quality of life satisfaction
,dysphagia,reduced QoL/ADL,Decrease,6.84,19,Draft,Dysphagia,Quality of life satisfaction
,pain,reduced QoL/ADL,Decrease,6.84,19,Draft,Pain,Quality of life satisfaction
,cognitive decline,reduced QoL/ADL,Decrease,6.84,19,Draft,Impaired cognition,Quality of life satisfaction
,first stroke,reduced QoL/ADL,Decrease,6.84,19,Draft,Ischemic stroke_1.0,Quality of life satisfaction
,second stroke,reduced QoL/ADL,Decrease,6.84,19,Draft,Ischemic stroke_2.0,Quality of life satisfaction
,second stroke,aphasia,Increase,6.84,19,Draft,Ischemic stroke_2.0,Aphasia
,first stroke,aphasia,Increase,6.84,19,Draft,Ischemic stroke_1.0,Aphasia
,aphasia,reduced QoL/ADL,Decrease,6.84,19,Draft,Aphasia,Quality of life satisfaction
,age,first stroke,Increase,6.84,19,Draft,Age factor,Ischemic stroke_1.0
,age,cognitive decline,Increase,6.84,19,Draft,Age factor,Impaired cognition
,age,pneumonia,Increase,6.84,19,Draft,Age factor,Pneumonia
,immobility before stroke,first stroke,Increase,6.0,19,Draft,Impaired mobility,Ischemic stroke_1.0
,immobility,second stroke,Decrease,6.0,19,Draft,Impaired mobility_2.0,Ischemic stroke_2.0
,depression before stroke,first stroke,Increase,6.84,19,Draft,Depressive disorder_1.0,Ischemic stroke_1.0
,pneumonia,antibiotics,Increase,6.84,19,Draft,Pneumonia,Antibiotic therapy
,antibiotics,death,Decrease,6.84,19,Draft,Antibiotic therapy,Death
,depression,antidepressants,Increase,6.84,19,Draft,Depressive disorder_2.0,Antidepressant therapy
,antidepressants,reduced QoL/ADL,Increase,4.26,19,Draft,Antidepressant therapy,Quality of life satisfaction
,speech therapy,aphasia,Decrease,6.84,19,Draft,Speech therapy,Aphasia
,psychotherapy,depression,Decrease,6.84,19,Draft,Psychotherapy,Depressive disorder_2.0
,psychotherapy,cognitive decline,Decrease,2.38,19,Draft,Psychotherapy,Impaired cognition
,physiotherapy,immobility,Increase,6.84,19,Draft,Physical therapy procedure,Impaired mobility_2.0
,physiotherapy,severe disability,Decrease,6.84,19,Draft,Physical therapy procedure,Disability
,social work,reduced QoL/ADL,Increase,6.84,19,Draft,Social worker involved,Quality of life satisfaction
,secondary prevention,second stroke,Decrease,6.84,19,Draft,Secondary prevention,Ischemic stroke_2.0
,primary prevention,first stroke,Decrease,6.84,19,Draft,Primary prevention,Ischemic stroke_1.0
,physical exercise,first stroke,Decrease,6.84,19,Draft,Exercises regularly,Ischemic stroke_1.0
,physical exercise,second stroke,Decrease,6.84,19,Draft,Exercises regularly,Ischemic stroke_2.0
,physical exercise,cognitive decline,Decrease,6.84,19,Draft,Exercises regularly,Impaired cognition
,care giving,death,Decrease,4.08,19,Draft,Care regime,Death
,social work,care giving,Increase,3.07,19,Draft,Social worker involved,Care regime
,multimodal pain therapy,pain,Decrease,6.84,19,Draft,Pain management,Pain
,botolinum toxin,spasticity,Decrease,6.84,19,Draft,Injection of botulinum toxin,Spasticity
,cognitive training,cognitive decline,Decrease,5.0,19,Draft,Cognitive skills training,Impaired cognition
Christoph,hypertension,first ischemic stroke,Increase,6.84,20,Draft,Hypertensive disorder,Ischemic stroke_1.0
Christoph,hypertension,second ischemic stroke,Increase,6.84,20,Draft,Hypertensive disorder,Ischemic stroke_2.0
Christoph,first ischemic stroke,second ischemic stroke,Increase,6.84,20,Draft,Ischemic stroke_1.0,Ischemic stroke_2.0
Christoph,first ischemic stroke,death,Increase,6.84,20,Draft,Ischemic stroke_1.0,Death
Christoph,second ischemic stroke,death,Increase,6.84,20,Draft,Ischemic stroke_2.0,Death
Christoph,aging,recovery level,Decrease,6.84,20,Draft,Age factor,Postprocedural recovery status
Christoph,aging,death,Increase,6.84,20,Draft,Age factor,Death
Christoph,aging,first ischemic stroke,Increase,6.84,20,Draft,Age factor,Ischemic stroke_1.0
Christoph,aging,second ischemic stroke,Increase,6.84,20,Draft,Age factor,Ischemic stroke_2.0
Christoph,second ischemic stroke,recovery level,Decrease,6.84,20,Draft,Ischemic stroke_2.0,Postprocedural recovery status
,first ischemic stroke,recovery level,Decrease,2.68,20,Draft,Ischemic stroke_1.0,Postprocedural recovery status
,B-cell infiltration,cognition,Increase,2.68,20,Draft,Ethnicity,Impaired cognition
,aging,cognition,Increase,6.84,20,Draft,Age factor,Impaired cognition
,hypertension,cognition,Increase,4.08,20,Draft,Hypertensive disorder,Impaired cognition
,first ischemic stroke,cognition,Increase,2.06,20,Draft,Ischemic stroke_1.0,Impaired cognition
,second ischemic stroke,cognition,Increase,6.84,20,Draft,Ischemic stroke_2.0,Impaired cognition
,systemic IL6,recovery level,Decrease,6.0,20,Draft,Interleukin-6,Postprocedural recovery status
,brain IL6_time1,recovery level,Increase,6.0,20,Draft,Interleukin-6_1.0,Postprocedural recovery status
,systemic IL6,second ischemic stroke,Increase,6.84,20,Draft,Interleukin-6,Ischemic stroke_2.0
,systemic IL6,first ischemic stroke,Increase,6.84,20,Draft,Interleukin-6,Ischemic stroke_1.0
,collateralization,stroke volume,Increase,6.84,20,Draft,Increased collateral circulation,Increased cardiac stroke volume
,first ischemic stroke,hemispheric atrophy,Increase,6.84,20,Draft,Ischemic stroke_1.0,Cerebral atrophy
,second ischemic stroke,hemispheric atrophy,Increase,6.84,20,Draft,Ischemic stroke_2.0,Cerebral atrophy
,hypertension,hemispheric atrophy,Increase,3.68,20,Draft,Hypertensive disorder,Cerebral atrophy
,aging,hemispheric atrophy,Increase,6.84,20,Draft,Age factor,Cerebral atrophy
,endothelial proliferation,recovery level,Increase,6.84,20,Draft,Procedure type,Postprocedural recovery status
,endothelial proliferation,blood brain barrier integrity,Decrease,6.84,20,Draft,Procedure type,Blood-brain barrier
,blood brain barrier integrity,B-cell infiltration,Increase,6.84,20,Draft,Blood-brain barrier,Ethnicity
,microglial proliferation,neuronal survival,Decrease,6.84,20,Draft,Gender,Procedure
,brain IL6_time2,recovery level,Decrease,2.68,20,Draft,Interleukin-6_2.0,Postprocedural recovery status
,astrocytic proliferation,recovery level,Increase,2.68,20,Draft,Observation period type,Postprocedural recovery status
,astrocytic proliferation,neuronal survival,Increase,2.68,20,Draft,Observation period type,Procedure
,endothelial proliferation,neuronal survival,Increase,5.2,20,Draft,Procedure type,Procedure
,collateralization,first ischemic stroke,Decrease,5.2,20,Draft,Increased collateral circulation,Ischemic stroke_1.0
,collateralization,second ischemic stroke,Decrease,5.2,20,Draft,Increased collateral circulation,Ischemic stroke_2.0
